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Abstract 
Flaviviruses (family Flaviviridae, genus Flavivirus) are a group viral pathogens 
responsible for causing disease and death in both humans and animals. Mosquito saliva 
potentiates Flavivirus infection in both in vitro and in vivo models; however, it remains unknown 
whether saliva from different species differentially potentiates infection. By inoculating the 
saliva of different mosquito species plus WNV onto Vero cells, plaque assays were used to study 
if saliva could differentially potentiate WNV infection. It was found that while there was no 
significant difference between Ae. aegypti and Ae albopictus saliva (p=0.19), more interestingly 
was that both saliva treatments had a significant reduction in plaques formed compared to virus 
alone (p= 0.01 and p=0.00). The presence of mosquito saliva appears to exert a protective effect 
in vitro when WNV is present.  
It also remains to be elucidated as to whether Canadian mosquitoes are able to spread 
Zika virus. By orally infecting wild caught mosquitoes with a ZIKV infected sugar meal and 
detecting the presence of virus 10 and 14 days post infection (d.p.i.), the vector competence of 
Canadian mosquitoes was evaluated. It was found that after 10 (n=50) and 14 d.p.i. (n=32), 2% 
and 0% of a population of Culex pipiens mosquitoes were found to be able to become infected 
and transmit the virus, respectively. Although Culex pipiens mosquitoes from the Niagara region 
may not be vectors of ZIKV, that does not negate other Canadian mosquitoes as being potential 
vectors. 
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1.1 Biology of Flaviviruses 
Flaviviruses (family Flaviviridae, genus Flavivirus) are a group viral pathogens 
responsible for causing disease and death in both humans and animals. Flavivirus takes its name 
from the Latin flavus, or yellow, the symptom jaundice caused by yellow fever virus (YFV). 
Other related viruses within the genus include Dengue virus (DENV), West Nile virus (WNV) 
and Zika virus (ZIKV). Primarily spread by mosquitoes, infected humans can exhibit symptoms 
ranging from mild flu-like conditions to potentially fatal meningitis, encephalitis, and 
hemorrhagic fever. Teratogenic effects and neurodegenerative diseases have also been linked to 
certain flavivirus infections.   
 
1.1.1 Molecular Structure 
Mature Flavivirus virions are spherical in shape, approximately 50nm in diameter 
(Murphy, 1980). They are composed of a single stranded, positive sense RNA genome encased 
by capsid protein. It is housed within a host-derived lipid bilayer that is covered by 180 copies of 
both envelope and membrane glycoproteins. 
 
1.2 Genome Organization  
Nearly 11 Kb long, the 5' capped but 3' non-polyadenylated tail genome encodes a single 
open reading frame (ORF) that is approximately 3400 codons long (Cleaves and Dubin, 1979). 
The flanking 5' and 3' -noncoding regions (NCR) of flaviviruses are roughly 100 and 550 
nucleotides long, respectively (Wengler et al., 1978), depending on strain. 
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1.2.1 5'-Noncoding Region 
  The 5' NCR is not translated but plays an integral role in the translation of the ORF. 
While the 5' NCR sequence varies among viruses within the genus, homologous secondary 
structures have been observed in both the 5' positive and 3' negative strands. Brinton and Dispoto 
(1988) described conserved long RNA stem-loop (SL) structures near the terminal end of the 5' 
NCR of similar size and shape for a variety of flaviviruses and postulated their importance in 
regulating translation due to conservation of structure despite differences in RNA sequences. 
Cahour et al. (1995) showed that mutant strains with deletions in DENV 5' NCR or in the 
complementary region of the negative strand, limited translation efficiency in vitro. RNA 
transcripts from the mutant strains reached 40% compared to wild- type virus transcripts. 
Virulence was also noted to be significantly reduced or removed when mammalian and insect 
cells were infected in vitro. The 3' negative strand has also been implicated in interacting with 
host factors. Shi et al. (1996) found that various cytoplasmic hamster cell proteins bound to the 
3’ terminal 75 nt of the WNV minus-strand RNA. Li et al. (2002) showed that the high affinity 
proteins were TIAR (T-cell intracellular antigen related), RNA binding proteins with RNA 
recognition motifs (RRM). It was also found that WNV replication in a TIAR knockout murine 
cell line was reduced highlighting the importance of NCRs interacting with host factors.   
  
1.2.2 3'- Noncoding Region  
 Like the 5' NCR, the 3' NCR shows sequence variation among viruses but shared 
homologous secondary structures such as the long RNA SL (Grun et al., 1986). It contains 3 
domain regions, Domain I is a hypervariable region that is followed by two stem loop domains 
(Wang et al., 1996). Domain II assumes a dumbbell (Silva et al., 2008) structure while Domain 
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III contains a short hairpin and stem loop elements (Davis et al., 2013; Sztuba-Solinska et al., 
2013). Studies by Zeng et al. (1998) showed that mutant strains of DENV with deletions or 
substitutions involving a 3' NCR SL resulted in reduced or abolished virulence when inoculated 
in mammalian or insect cells.  Within the study, it was noted that one mutant with a 7 bp 
substitution within the SL region grew well in LLC-MK2, monkey kidney cells, but saw reduced 
amplification in a C6/36 mosquito cell line suggesting an interaction with host factors. Blackwell 
and Brinton (1997) showed through UV cross-linking and gel mobility shift assays that WNV 
RNA not only bound hamster cell proteins to the 5' NCR SL but also in the 3' SL. Subsequent 
purification identified one of the proteins as translation elongation factor 1A (EF1A) (Blackwell 
and Brinton, 1997), a protein known to transport tRNA to ribosomes suggesting its role as a host 
factor that influences translation. The presence of subgenomic flavivirus RNA (sfRNA) is also 
dependent on the 3’ NCR. These small molecules (300-500 nt) are the product of incomplete 
digestion by host cell nucleases that disassociate on the 3’NCR (Pijlman et al., 2008). Full length 
sfRNAs have been shown to increase virulence in mice (Liu et al., 2014) inhibit antiviral 
immune responses such interferon (Schuessler et al., 2012) and Dicer (Schnettler et al., 2012) 
and inhibit host cell nuclease Xm1, preventing viral genome digestion (Moon et al., 2012). 
 
1.2.3 Viral Proteins   
 When translated, the single ORF yields one large continuous polyprotein that is later 
spliced into 10 smaller proteins. The N-terminal region of the viral genome encodes 3 structural 
proteins: the capsid (C), membrane (M), which is first translated as premembrane (prM), and 
envelope (E) (Rice et al., 1985). The remaining region within the ORF encodes the other 7 non-
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structural proteins: NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5, which regulate and assist 
replication (Rice et al., 1985). 
 
1.2.4 Structural Proteins 
 
1.2.5 Capsid Protein 
Capsid is a small, very basic protein (~11kDa) expressed with 114 amino acids (aa), 
which is translocated to and inserted into the endoplasmic reticulum (ER) via a C-terminus signal 
sequence. In the ER lumen, cellular signal peptidase cleaves the signal sequence freeing the rest 
of the polyprotein while the N- terminus end of the signal sequence located on the cytoplasmic 
side is later cleaved by viral proteases NS2B/3 thus releasing mature C protein (Amberg et al., 
1994; Boege et al., 1983; Trent, 1977). C protein has 4 alpha-helices linked by short loops which 
coalesce to form 2 conserved segments: a hydrophobic and a cationic region respectively 
(Markoff et al., 1997), later visualized through NMR and X-ray crystallography (Dokland et al., 
2004; Ma et al., 2004). Known to encapsidate the viral genome, it is assumed that the C-terminus 
alpha4- alpha4' region associates with viral RNA while the hydrophobic core within the alpha2-
alpha2' region associates with both viral and host lipid membranes (Markoff et al., 1997). Kofler 
et al. (2002) highlighted the structural importance of C protein using mutant strains of tick-borne 
encephalitis virus (TBE). Strains with deletions corresponding to the internal hydrophobic 
domain yielded a decrease in TBE virions in vitro and an increase in the formation of attenuated 
yet immunogenic subviral particles which closely resembled recombinant subviral particles 
(RSP), virions with E and M protein expressed only. Interestingly non- traditional roles have 
been found. Known to be translocated to the ER, C protein was also discovered to accumulate 
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specifically within the nucleolus and has been implicated in mediating apoptosis 
(Bhuvanakantham et al., 2010; Bulich & Aaskov, 1992; Westaway et al., 1997). Samuel et al. 
(2016) discovered a novel function in the mosquito host showing that C protein has RNA 
silencing properties effectively limiting an immune response in Aedes aegypti (Linnaeus) 
mosquitoes, making it easier for flaviviruses to establish infection.  
  
1.2.6 Membrane Protein  
  M protein (~10 kDa) is initially expressed as the 165 aa long, pre-membrane protein 
(prM) that is glycosylated. It later undergoes cleavage from cellular furin protease, releasing the 
pr peptide from the now mature 77 aa long M (Stadler et al., 1997). Translocated to the ER 
lumen via an N- terminus signal sequence, two C-terminus transmembrane domains (TMD) 
anchor prM to the ER membrane (Hsieh et al., 2011). The anchor closest to the C-terminus end 
acts as the signal sequence for the connected E protein, where it too is translocated to the ER 
lumen. prM is glycosylated in the ER lumen but awaits further maturation as the assembling 
virion traverses through the Golgi network (MacKenzie & Westaway, 2001). Located near the 
N- terminus region are 1-3 glycosylation sites embedded within 2 beta-sheets linked by disulfide 
bridges (Nowak and Wengler, 1987). prM and E interact via a heterodimeric complex post 
polyprotein synthesis (Lorenz et al., 2002), revealing the chaperone role prM assumes in 
regulating E folding (Konishi and Mason, 1993; (Zheng et al., 2014). Li et al. (2008) later 
visualized the interaction capturing pr peptide in complex with an important ectodomain of E. 
Flavivirus prM associates with E due to it being closely positioned distal to E domain II (DII) 
inside the heterodimer, sterically hindering E fusion-loop (Zhang et al., 2003), preventing 
premature viral fusion within the cell (Yu et al., 2009). 
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1.2.7 Envelope protein 
  E protein (~53 kDa) is expressed as a 495 aa protein that is glycosylated and that coats 
the outermost layer of the virion. It is responsible for mediating binding to host cellular 
membranes thus prompting fusion. It is composed of 3 domains: Domain I which contains the N-
terminus and assumes a beta barrel configuration (Rey et al., 1995); Domain II is comprised of 
two finger-like structures and contains a hydrophobic fusion loop that mediates insertion into the 
host cellular membrane (Allison et al., 2001); Domain III is an immunoglobulin-like domain 
thought to interact with and bind to cellular receptors (Rey et al., 1995). Virion fusion and 
maturation require structural rotations between all 3 domains (Bressanelli et al., 2004; Modis et 
al., 2004) 
  
1.2.8 Non-Structural Proteins 
 
1.2.9 NS1  
  NS1 (~46 kDa) is embedded into the lumen of the ER after cleavage from the rest of the 
polyprotein at its N-terminus by host signal peptidase and an unknown enzyme at the C-terminus 
(Chambers et al., 1990; Falgout et al.,1989). Found within cells, it has also been located on the 
cell surface, as well as being secreted from mammalian cells (Mason, 1989; Post et al., 1991; 
Smith et al., 1970; Winkler et al., 1988). Within the cell, NS1 is thought to aid in RNA 
replication as it has been observed localizing to vesicle packets (VP), produced from the ER, 
along with other viral proteins, where the replication complex can be assembled (Mackenzie et 
al., 1998). Mutant YFV strains with changes in NS1 glycosylation sites reduced rates of RNA 
replication, virus propagation and virulence (Muylaert et al., 1996). Specifically, NS1 seems to 
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be involved in early RNA replication. Lindenbach and Rice (1997), found that a YFV mutant 
with a large deletion within the NS1 gene produced undetectable amounts of RNA as determined 
by sensitive assays for detecting the first cycle of minus strand synthesis. NS1 plays an integral 
role in the formation and/or function of host ribosomal proteins where it is able to localize the 
subunits at sites of viral replication (Cervantes-Salazar et al., 2015). In the presence of siRNA, 
decreases in viral translation, replication and virion production were noted (Cervantes-Salazar et 
al., 2015). Extracellular activity of NS1 was first postulated to modulate host immune response 
to facilitate infection (Chang et al., 2002; Falconar, 1997), and was later discovered by Kurosu et 
al. (2007) to associate with complement system proteins, inhibiting viral recognition of infected 
cells. Another form of NS1, NS1’ also exists both inter and extracellularly and is the result of 
alternative splicing. (Melian et al., 2010). It has been found to associate with NS3 and NS5 
replication complexes (Takamatsu et al., 2014), as well as localizing with NS1 where it can offer 
substituted function (Young et al., 2013). 
 
1.2.11 NS2A  
NS2 (~22 kDa) is a hydrophobic protein that spans the ER membrane. Cleaved at the N-
terminus region by an unknown enzyme while the C-terminus is cleaved by viral serine protease 
in the cytoplasm (Falgout and Markoff 1995). Found to bind with NS3 and NS5 proteins, 3'NCR 
sequences, as well as localizing to VPs (Mackenzie et al., 1998), NS2A has been implicated in 
mediating RNA replication, virion formation, viral dissemination as well as regulating host 
immune responses (Leung et al., 2008; Liu et al., 2006; McElroy et al., 2006; Rossi et al., 2007). 
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1.2.12 NS2B 
  NS2B (~14 kDa) is a membrane spanning protein that associates and forms a complex 
with NS3 protein thus being a cofactor for the serine protease activity in NS3 which is required 
for the cleavage of the polyprotein (Falgout et al., 1991). NS3 does not fold properly without 
interaction with NS2B and thus has no activity (Kim et al., 2013). Studies using strains with 
mutations disrupting the NS2B-NS3 complex removed serine protease activity (Chambers et al., 
1993; Jan et al., 1995). 
 
1.2.13 NS3 
  NS3 (~70 kDa) plays an integral role in a variety of functions including RNA replication 
and polyprotein cleavage. Known to associate with NS2B (Falgout et al., 1991), it has also been 
found to localize to VPs and convoluted membranes (CM), sites of polyprotein processing 
(Westaway et al. 1997). Protease activity of NS3 was located to the N-terminal third of the 
protein, being predicted first by Gorbalenya et al. (1989a) and later proven by the observation of 
strains with mutations within the catalytic triad that saw reduced serine protease activity 
(Chambers et al., 1990). It also has been found to exert protease activity on host cell proteins that 
would try to prevent infection (Yu et al., 2012). Located within the C-terminus region are 
encoding regions for helicases, helping unwind RNA duplexes (Gorbalenya et al. 1989b), where 
it was later found to have helicase, nucleoside 5’-triphosphatase (NTPase), and RNA 5’-
triphosphatase (RTPase) activity (Li et al., 1999). 
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1.2.14 NS4A and NS4B 
  NS4A and NS4B (16 and 27 kDa respectively) are hydrophobic proteins that have have 
been implicated in mediating RNA replication as they have been observed to localize to both 
VPs and CMs as well as directly interacting with NS1 (Mackenzie et al., 1998; The C-terminus 
of NS4A contains a signal sequence that translocates NS4B to the ER lumen. NS1 and NS4A/B 
complexes can associate with complement system proteins to counteract immune responses 
(Muller and Young, 2013). 
 
1.2.15 NS5 
  NS5 (103 kDa) is a highly conserved, large protein implicated in capping, methylation, 
and replication of the genome (Dong et al., 2012; Egloff et al., 2007). It consists of an N-
terminus methyltransferase and a C-terminus RNA- dependent-RNA polymerase domain 
(Ackermann and Padmanabhan 2001; Guyatt et al., 2001; Nomaguchi et al., 2004). 
  
1.3 Life Cycle 
  The life cycle of WNV is well studied and will serve as the model for flavivirus infection 
and replication. WNV virions collide with the surfaces of cells gaining entrance only by 
associating with target cellular surface receptors. Many cellular surface proteins have been 
implicated as the receptor for West Nile virus; however, two of the most studied and likely 
candidates include mammalian C-type lectin receptor DC-SIGNR (Dendritic Cell-Specific 
Intercellular adhesion molecule-3-Grabbing Non-integrin homologue) and mosquito galactose 
specific C-type lectin-1 (mosGCTL-1). DC-SIGNR is thought to interact with glycosylated prM 
and E proteins of the WNV virion (Davis et al., 2006). WNV is still able to bind to cells without 
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DC-SIGNR suggesting a wider variety of receptors (Davis et al., 2006). Mosquito cellular 
receptor mosGCTL-1 was found to be able to bind WNV enabling attachment and enhanced 
entry into mosquito cells (Cheng et al. 2010). After binding to a receptor, the virion enters the 
cell through a process known as receptor mediated clathrin dependent endocytosis. The virion 
enters as the plasma membrane and invaginates around to form an endosome. This vesicle 
containing the virus is formed with the protein clathrin. The triskelion shaped clathrin and its 
accessory proteins polymerize around the vesicle mediating entry into the cell. WNV is thought 
to follow this mode of entry as studies using compounds specifically inhibiting clathrin 
dependent endocytosis greatly inhibited infection (Chu et al., 2006). As the endosome enters the 
cell a decrease in pH causes the virion E protein to undergo a conformational change, allowing it 
to fuse with the perimeter of the endosome. This fusion event allows the viral genome to be 
released from the endosome and into the cytoplasm of the cell (Brinton 2002). The viral mRNA 
associates with ribosomes on the ER where it is translated into a polyprotein. This polyprotein is 
then processed within the endoplasmic reticulum where it is cleaved by cellular proteinases 
resulting in 3 structural and 7 non-structural proteins. The 7 non-structural proteins mediate the 
replication of viral RNA through the formation of an RNA replicase complex. These complexes 
associate with the viral genome creating more copies used to further replication and associate 
with the structural proteins when packaging new virions. The virions are assembled as they 
traverse through the Golgi apparatus where upon maturation, they are exit from the cell through 
exocytosis. After the virus leaves the cell, it is free to interact with adjacent cells, continuing the 
cycle (Brinton 2002). 
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1.4 West Nile Virus 
In 1999, New York City health officials noticed an increase of patients afflicted with 
meningoencephalitis (CDC, 1999). Around the same time, local crow populations were seeing 
higher fatalities with zoos reporting suspicious deaths of exotic avian species also afflicted with 
meningoencephalitis (CDC, 1999). Sera isolations from both human and avian cases confirmed 
through PCR and ELISA that for the first time WNV had been found in the Western hemisphere. 
By the end of the year, 59 patients were hospitalized as well as 7 deaths recorded due to 
complications caused by the WNV NY-99 strain (Nash, et al., 2001). Its eventual spread 
throughout North America while causing numerous more outbreaks has resulted in WNV being 
labeled as the leading cause of mosquito-borne/ epidemic encephalitis in the United States (CDC, 
2012).  
  West Nile Virus (WNV; family Flaviviridae, genus Flavivirus) is an enveloped, positive-
sense, single-stranded RNA virus. Approximately 11 kb long, it contains all the elements of a 
generic flavivirus as well as having a similar replication cycle. Originating in Africa, WNV has 
slowly spread throughout Europe, Asia, and the Americas causing death and neurotropic disease 
including meningitis and encephalitis. 
  
1.4.1 History 
  WNV was first isolated in 1937 from the serum sample of a febrile patient residing in the 
West Nile district of Uganda (Smithburn et al., 1940).  It was later determined to be a new 
neurotropic pathogen like other viruses belonging to the Japanese Encephalitis complex based on 
serological cross-reactivity (Smithburn, 1942). Philip and Smadel (1943) showed that WNV was 
most likely spread by infected mosquitoes with Work et al. (1955) discovering that birds acted as 
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reservoir hosts in an enzootic cycle with mosquitoes. Up until 1975, WNV fever epidemics in 
Israel and South Africa and a WNV meningoencephalitis outbreak in Europe were noted 
(Klingberg et al., 1959; Murgue et al., 2001; McIntosh et al., 1976). Unreported until 1994, large 
epidemics started to occur in Africa, Europe and the Middle East ultimately culminating in the 
surprising arrival of WNV in the Western hemisphere (Campbell et al., 2001; Murgue et al., 
2001). 
  
1.4.2 Phylogeny 
  Different strains of WNV can belong to one of two lineages (Lineage I and II) (Berthet et 
al., 1997). Lineage I strains of WNV are found globally including NY-99, most commonly 
associated with causing the New York outbreak of 1999 (Berthet et al., 1997; Lanciotti et al., 
1999). Differences in pathogenicity of strains have been noted within Lineage I (Brault et al., 
2007). Lineage II strains of WNV are endemic to sub-Saharan Africa and parts of Europe 
(Bakonyi et al., 2005). Lineage II strains of WNV have been associated with a reduced severity 
of disease and sporadic cases of neuroinvasion. Interestingly WNV NY-99 had been determined 
to be most closely related to a WNV isolate from Israel in 1998 (Lanciotti et al., 1999), although 
no explanation has been found for its arrival in the United States. 
  
1.4.3 Transmission cycle 
  In nature, WNV is propagated in an enzootic cycle between mosquitoes, predominantly 
from the genus Culex, and birds (Kilpatrick et al., 2005; Work et al., 1955). Mammals are 
generally considered to act as dead-end hosts as WNV never attains a sufficient viremia to be 
transmitted to feeding mosquitoes (Austgen et al., 2004; Bunning et al., 2002; Xiao et al., 2001). 
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While birds play an integral role in propagating WNV, certain avian species have been 
implicated in helping it spread. Common birds such as the American crow (Corvus 
brachyrhynchos), blue jay (Cyanocitta cristata) and house sparrow (Passer domesticus) develop 
high levels of viremia, increasing the likelihood of infecting feeding mosquitoes (Brault et al., 
2004; Komar et al., 2003; Langevin et al., 2005 Weingartl et al., 2004). Both mammalian and 
avian species that have been infected can exhibit symptoms of disease, but most commonly 
become asymptomatic carriers. Uninfected mosquitoes that feed on infected hosts can become 
infected depending on a variety of factors.  One of the most important is the concentration of 
virus. Turell et al. (2002) found that the minimum titer of WNV needed to infect different 
mosquito species was between 104 - 105 plaque forming units/ mL.  
 
1.5 Zika Virus 
 In 2014, numerous cases of patients with rash, fever and arthralgia were being reported in 
Brazil. Thought to be an outbreak of DENV or Chikungunya virus, it was later determined 
through qRT-PCR and ELISA that the culprit was ZIKV (Campos et al., 2015; Zanluca et al., 
2015). Although previously found in other parts of the world, the outbreak in Brazil marked the 
first time ZIKV had ever been found in the Western hemisphere. Worryingly, increased reports 
of microcephaly in newborns and neurodegenerative disease implicated ZIKV as being the 
causative agent. Spreading throughout the Americas and causing outbreaks, ZIKA has spurred 
research efforts in combatting both mosquitoes and virus to curb the spread of disease. 
  Zika virus (ZIKV; family Flaviviridae, genus Flavivirus) is an enveloped, positive-sense, 
single-stranded RNA virus Like WNV, it is ~11kb long and contains similar genetic elements. 
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Originating in Africa, ZIKV has slowly spread throughout Asia, Oceana, and the Americas and 
has been implicated in inducing teratogenic effects and causing neurodegenerative disease.  
  
1.5.1 History 
  ZIKV was first discovered in the Zika Forest of Uganda in 1947 from the blood of a 
febrile Sentinel Rhesus monkey (Dick, 1952; Dick et al., 1952). In 1948, it was then found in 
pools of Aedes africanus (Theobald) mosquitoes (Dick et al., 1952). Macnamara (1954) then 
found the first case of human infection by testing the sera sample of a febrile girl from Nigeria. 
Spreading out of Africa, ZIKV was detected in Asia for the first time when pools of Ae. aegypti 
mosquitoes collected from Malaysia tested positive for the virus (Marchette et al., 1969). The 
first human cases in Asia were then found in Indonesia (Olson et al., 1981). Until 2007, ZIKV 
only manifested itself through sporadic individual cases. Outbreaks in Gabon and Yap Island 
prompted investigation which revealed large populations of people testing positive for previous 
infection of ZIKV as well as implicating both Aedes hensilli (Farner) and Aedes albopictus 
(Skuse) mosquitoes as potential vectors (Duffy et al., 2009; Grard et al., 2014). An outbreak later 
occurred in French Polynesia where it has been estimated that 28,000 people were infected 
(Musso et al., 2014). Increased cases of Guillaine-Barre syndrome also seemed to coincide with 
the ZIKV outbreak. Finally, in 2014, ZIKV arrived in the Western hemisphere, first being 
detected in Brazil (Campos et al., 2015; Zanluca et al., 2015) before spreading throughout the 
Americas.  Reports of increased cases of microcephaly in Brazil during the ZIKV outbreak (Cao-
Lormeau et al., 2016) prompted great concern from neighboring countries anticipating its arrival. 
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1.5.2 Phylogeny 
  ZIKV has been assumed to belong to one of two lineages, African and Asian/American 
(Weaver et al. 2016). African strains of ZIKV can further be categorized into two groups. Group 
one or the Uganda cluster is predicated on the MR766 strain first found in Uganda (Dick et al., 
1952), which also includes strains from Senegal and Central African Republic (Weaver et al. 
2016). Group two or the Nigeria cluster includes strains isolated from both Nigerian and Senegal 
from 1968 to 1997 (Weaver et al. 2016). The Asian cluster is predicated on the P6-740 strain 
found in Malaysia (Marchette et al., 1969) and includes strains from Micronesia and French 
Polynesia (Oehler et al., 2014). Strains circulating throughout the Americas are assumed to be 
derived from an Asian strain based on comparative genomic studies (Enfissi et al., 2016). 
 
1.5.3 Transmission Cycle 
  How ZIKV is propagated in nature is debated. It has been assumed that ZIKV is 
maintained in an enzootic cycle between Aedes mosquitoes and an unknown nonhuman primate. 
Multiple studies since the discovery of ZIKV have implicated Aedes mosquitoes as being 
probable vectors such as the discovery of ZIKV positive wild caught mosquitoes, successful 
vector competence studies, as well their general abundance and previous history in spreading 
other flaviviruses. (Aliota et al., 2016; Amraoui et al., 2016; Boccolini et al., 2016; Dick, 1952; 
Duffy et al., 2009; Dick, 1952; Duffy et al., 2009; Grard et al., 2014; Grard et al., 2014; Guedes 
et al., 2016, Guo et al., 2016; Huang et al., 2016; Macnamara, 1954; Marchette et al., 1969; 
Weger-Lucarelli et al., 2016). The assumption of a nonhuman primate is based on the reasoning 
that it was first discovered from a Sentinel Rhesus monkey (Dick, 1952; Dick et al., 1952); 
however, those studies have postulated that nonhuman primates may not be the most suitable 
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reservoir hosts as it was rarely found in them. The transmission cycle requires further 
investigation. 
 
1.6 Implicated Vectors 
 
1.6.1 Culex mosquitoes 
  Species of mosquitoes belonging to the Culex pipiens species complex are thought to be 
primary vectors of WNV in North America due to their proliferation in urbanized areas 
(Vinogradova, 2000), the coinciding of outbreaks and Culex population peaks (Spielman, 2001), 
wild populations testing positive for WNV (Bernard et al., 2001), females being able to 
transovarially transmit the virus (Dohm et al., 2002) and their affinity for avian blood meals 
(Kilpatrick et al., 2005; Work et al., 1955). The two species most implicated in WNV 
transmission are Culex pipiens (Linnaeus) and Culex quinquefasciatus (Say), the northern and 
southern house mosquitoes, respectively. Their ability to survive in both temperate and tropical 
regions as well as their population distribution closely mirroring human activity makes them 
suitable candidates for transmitting WNV. While Culex mosquitoes are most commonly 
associated with WNV, they can also act as suitable vectors for a variety of other related diseases 
such as Japanese Encephalitis virus (JEV) and even ZIKV (Guedes et al., 2016, Guo et al., 2016; 
Takahashi, 1976). 
  It is theorized that ancestral Culex pipiens derived from an African species that 
eventually spread throughout Europe before arriving in the New World possibly in the 16th 
century (Vinogradova, 2000). It has been argued that their success was due to appropriating food 
and nutrients found in standing water left by humans and animals (Vinogradova, 2000). 
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Interestingly within the complex is a subspecies that does not require blood to mature a batch of 
eggs. Cx. pipiens form molestus exhibits autogenous behaviour, using only the nutrients and 
energy sequestered during the larval stage to develop its eggs. Cx. pipiens form molestus is 
thought to be a form of the complex that had adapted to survive cold European winters by 
surviving in manmade underground systems (Fonesca et al., 2004, Spielman et al., 2001).  
  
1.6.2 Aedes Mosquitoes 
  Aedes spp. mosquitoes, specifically from the subgenus Stegomyia, are largely responsible 
for spreading a variety of diseases throughout both the developed and undeveloped world. 
Known to transmit dengue, yellow fever, chikungunya, and Zika virus amongst other pathogens, 
they have evolved to associate closely with humans where they facilitate the spreading of these 
diseases. Their ability to lay eggs resistant to desiccation combined with their preference to lay 
eggs in artificial containers has facilitated the transport and spread of invasive species to new 
habitats, (Lounibos and Kramer, 2016; Powell and Tabachnick, 2013). Two of the most 
important disease vectors Ae. aegypti and Ae. albopictus have been implicated in helping spread 
numerous diseases due to their preference for human blood as well as being competent vectors 
for multiple arboviruses (Ponlawat and Harrington, 2005).  
  Ae. aegypti has been theorized to have originated in sub-Saharan Africa with the ancestor 
most resembling the present day Ae. aegypti form formusus (Tabachnick, 1991). It has been 
speculated that increasing drought conditions forced the ancestor to domesticate in water laden 
human settlements (Mattingly, 1967). Ae. albopictus has been theorized to have originated in the 
forests of Southeast Asia and fed on local wildlife (Paupy et al., 2009). Like Ae. aegypti, changes 
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in the surrounding environment led to the domestication of Ae. albopictus feeding on human 
populations. 
 
1.7 Vector Competency 
  For a mosquito to be considered a competent vector of an arbovirus, it must adhere to a 
set of rules proposed by Hardy et al. (1983): a primary infection of the midgut; virus 
disseminates throughout midgut epithelium; virus disseminates from the midgut to surrounding 
tissue; propagation of virus outside of midgut; infection of salivary glands; and the eventual 
transmission of virus through salivary secretions. Simply, virus must infect the midgut, 
disseminate throughout the body and finally infect the salivary glands where it can be secreted. 
While there are many factors that can influence vector competency such as intrinsic/genetic, 
behavioral, or even geographical, two important barriers to mosquito host infection are the 
midgut and salivary gland barriers.  
  
1.7.1 Midgut Barriers 
  The newly acquired viremic bloodmeal is quickly drawn into the midgut where the 
bloodmeal is to be processed for digestion. Virions enter the midgut lumen where they must 
attach to and infect the midgut epithelial cells. The process is time sensitive as virions must fuse 
with and enter midgut epithelial cells before the peritrophic matrix is secreted (Franz et al., 
2015). The peritrophic matric is a chitinous sac that can prevent virions in the gut lumen from 
interacting directly with epithelial cells. Maturation of the matrix has been observed taking 
anywhere from 4-12 hours post secretion in Ae. aegypti (Perrone and Spielman, 1988). 
Successful entry into the epithelial cells proceeds with viral RNA replication at the endoplasmic 
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reticulum membrane. While the location of viral maturation can differ depending on the virus or 
mosquito species, it is generally accepted that newly propagated virions must be able to leave the 
midgut epithelium to reach the salivary glands later. SLEV virions were observed to accumulate 
within the midgut epithelium due to an intact basal lamina suggesting it acts as a barrier 
secondary barrier (Whitfield et al., 1973). Weaver et al. (1988) observed that when the midgut of 
Culiseta melanura (Coquillett) was infected with eastern equine encephalitis virus (EEEV), 
detrimental changes to the basal lamina occurred. Weaver et al. (1988) speculated it was a 
mechanism employed by the virus to escape the midgut. It is assumed that the virus propagates 
again finding suitable tissue to infect to increase the chances of infecting the salivary glands. 
 
1.7.2 Salivary Gland Barriers 
  To date there exists no molecular mechanism that explains both salivary infection and 
escape barriers sufficiently. Rosomer et al. (2005) postulated that the basal lamina of the salivary 
glands may resemble midgut epithelial basal lamina, acting as a physical barrier for virion entry 
and/or escape. Innate differences between lobes have been proposed as a potential reason for 
salivary gland infection. Juhn et al. (2011) showed that certain transcripts in Ae. aegypti glands 
localized only to the median or lateral lobes while others were found throughout and may play a 
role in determining susceptibility. Structurally, only the lateral lobes contain cuticular 
filamentous membrane extensions which have been found to be required attachment sites for 
Sindbis virus (SINV) (Ciano et al., 2014). The induction of cytopathic effect and salivary gland 
cell apoptosis by SINV has been thought to be a requirement for transmission of other viruses. 
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 1.8 Mosquito Taxonomy and Biology 
  Mosquitoes are categorized in the family Culicidae, under the Order Diptera. These "True 
flies" are known to have a pair of wings and halteres. In Ontario, Canada alone, there are 69 
species of mosquitoes with many acting as important or potential vectors for disease (Giordano 
et al., 2015). Known for their voracious appetite for blood, mosquitoes have long plagued 
humans for thousands of years. Their unique life cycle and wide preference of animals to feed 
from has led to the establishment of successful mosquito populations all over the world.  
 
1.8.1 Life Cycle 
  Mosquitoes develop through 4 life stages: egg, larva, pupa and adult. The first 3 stages 
are aquatic while the adult stage is terrestrial. Generally, development from egg to newly 
emerged adult lasts 1 to 2 weeks. The rate of development and size of the adult are dependent on 
the amount of nutrients acquired by the larva and the temperature of the water they were reared 
in. Adult mosquitoes in the wild are assumed to live 1-2 weeks while those bred in captivity have 
been noted to live up to a month (Clements, 1993) 
 
1.8.2 Egg Stage 
  Adult female mosquitoes with a mature batch of eggs generally seek damp environments 
to oviposit. Depending on the genus of the mosquito, the structure and placement of eggs can 
differ. Aedes mosquitoes lay their eggs individually on moist substrates near but above water 
level waiting for submersion (Gillett, 1956). Culex mosquitoes lay their eggs on the water's 
surface in a floating mass called a raft (Christopher, 1945). While both require approximately 2-3 
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days to hatch, Aedes eggs have evolved to withstand months of drought while Culex eggs lack 
this adaptation (Clements, 1993) 
  
1.8.3 Larval Stage 
  Newly hatched Aedes and Culex larvae scrape or filter feed on organic substrates. 
Although aquatic, mosquito larvae fulfill their oxygen requirements by drawing air from the 
surface through a structure near their tail end known as a siphon. Larvae submerged to either eat 
or hide from predators, spending most of their time near the surface. During this stage, the larvae 
continually eat, grow and shed its exoskeleton 4 times, developing through sub stages known as 
instars. The 4th instar molts for the last time into the next developmental stage known as the 
pupa.  
   
1.8.4 Pupal Stage 
  Pupae lose function of their mouthparts due to the fusion of the cephalothorax and 
relinquish their ability to feed but acquire a hardened cuticle to protect the developing adult 
mosquito within. Two trumpet like structures found dorsally replace the ventral siphon as the 
sole breathing apparatus. Although rigid in appearance, pupae still exhibit larvae-like mobility, 
being capable of submerging from the surface and escaping danger. When development has 
ceased, the pupa floats to the top and the adult mosquito emerges from the cuticle (Clements, 
1993).  
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1.8.5 Adult Stage 
  Adult mosquitoes readily adapt to their terrestrial surroundings aided by their ability to 
fly. Males generally develop faster than females and are usually the first to emerge. Compared to 
the female, males tend to be smaller, have more plumose antennae, and can have elongated palpi 
depending on the genus. Both sexes have somewhat similar mouthparts and require energy from 
carbohydrate sources such as fruit or honeydew, however the distinguishing characteristic of 
blood feeding is female only. Mated female Aedes mosquitoes seek blood to mature their batch 
of eggs. Proteins and other factors from blood help to develop their eggs however, blood feeding 
in mosquitoes is not always required. Some species of Culex mosquitoes have autogenous 
females, producing eggs without the need for blood, unlike the anautogenous Aedes mosquito 
(Roubaud, 1929) 
 
1.8.6 Blood Feeding 
  While not exclusive to mosquitoes, hematophagy or blood feeding is one of their most 
commonly associated characteristics. Using a variety of visual and sensory cues including CO2, 
heat, and host-derived odors, hungry females locate potential blood meals from attractive animal 
hosts. After landing on a host the female readies her specialized mouth parts, the proboscis, 
revealing the stylets and shallowly penetrates the skin trying to locate suitable blood vessels. 
This process is also known as probing. When a suitable site has been located, the mosquito starts 
to feed by drawing blood. During probing and feeding, the mosquito salivates, releasing a variety 
or enzymes into the host to facilitate blood feeding. Drawn blood is immediately diverted to the 
insect midgut, where it is later processed and digested (Clements, 1993). 
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1.8.7 Salivary Glands Structure 
  Both male and female mosquitoes contain a pair of salivary glands located within the 
thorax, above the forelegs. In most species, each gland is tri-lobed which all converge to a single 
shared duct. A salivary gland consists of a short medial lobe flanked on both sides by two longer 
lateral lobes. The medial lobe consists of both a neck and distal region while the lateral lobes can 
be further divided into the proximal, intermediate, and distal regions. Each lobe is composed of a 
layer of epithelial cells that surround a primary duct (James and Rossignol, 1991). The pair are 
connected internally to the base of the proboscis via the salivary valve and thus saliva can readily 
be secreted during feeding. 
  
1.8.8 Salivary Components 
  While salivary gland extracts from various insect species have been shown to contain 
approximately 120 different proteins only a small fraction of them have been properly 
characterized for their biochemical function (Almeras, 2010). The proteins that have been 
identified include the members of the 5’- nucleosidase, mucin and D7 proteins. The 5’- 
nucleosidase protein family consists of enzymes that inhibit the hemostatic response in vertebrate 
blood meals (Champagne, 1995). A well-known protein found in blood feeding species of 
mosquito saliva is the enzyme apyrase. This approximately 64 kDa sized protein (Francischetti, 
2002) inhibits platelet aggregation by catalyzing the degradation of adenosine triphosphate 
(ATP) to adenosine monophosphate (AMP), limiting the availability of adenosine diphosphate 
(ADP), a stimulus needed for the hemostatic event to occur (Ribeiro, 1985). Mucins are 
glycoproteins found in mosquito saliva. These proteins are thought to lubricate the salivary canal 
as well as play a role in the modulation of an immune response in vertebrate hosts (Valenzuela, 
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2003). D7 proteins are unique as they are only found in the salivary glands of sand flies and 
mosquitoes (Valenzuela, 2002). There exist two types of D7 proteins: long D7 (28-30 kDa) 
found in sandflies and mosquitoes, and short D7 (15-20 kDa) found only in mosquitoes (Arca, 
1999). These proteins play a role in inhibiting the activation of host plasma (Valenzuela, 2003). 
The protein hamadarin (16 kDa) had been shown to inhibit the plasma contact system, thus 
delaying the release of bradykinin, a peptide that mediates an inflammatory response (Isawa, 
2002). 
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Chapter 2 
Differential Potentiation of Flavivirus Infection Using Saliva Collected from a Variety of Female 
Mosquitoes 
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2.1 Abstract 
As female mosquitoes feed on hosts for blood, they secrete saliva. This saliva contains a 
variety of proteins and factors that helps facilitate feeding. If infected with WNV, the virus is 
transmitted along with the saliva. Mosquito saliva potentiates Flavivirus infection in both in vitro 
and in vivo models; however, it remains unknown whether saliva from different species 
differentially potentiates infection. By inoculating the saliva of different mosquito species plus 
WNV onto Vero cells, plaque assays were used to study if saliva could differentially potentiate 
WNV infection. It was found that while there was no significant difference between Ae. aegypti 
and Ae albopictus saliva (p=0.19), more interestingly was that both saliva treatments had a 
significant reduction in plaques formed compared to virus alone (p= 0.01 and p=0.00). The 
presence of mosquito saliva appears to exert a protective effect in vitro when WNV is present. 
 
2.2 Introduction 
 Whether it be drinking honeydew or imbibing a blood meal, female mosquitoes secrete 
saliva during feeding (Eliason, 1963; Ribeiro., et al., 1984). As they salivate, they release a 
variety of proteins and factors that exhibit a variety of functions. During blood feeding salivary 
components with anticlotting, antiplatelet and vasodilatory properties are secreted to facilitate the 
process (Ribeiro., et al., 1984). If the mosquito has a disseminated infection of a flavivirus, then 
potentially the virus can be secreted along with the saliva. Interestingly, mosquito saliva not only 
serves to help mosquitoes, but also seems to influence the virulence of flaviviruses in bitten 
hosts. Mice and chicken previously inoculated with mosquito saliva and then virus or given virus 
mixed with saliva showed increased viremia and had higher rates of mortality compared to those 
without saliva (Schneider et al., 2006; Schneider et al., 2007; Styer, et al., 2006; Styer et al., 
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2011). This potentiation effect has been linked to changes in the immune response induced by 
factors found within the saliva (Schneider et al., 2010). It has been shown that mosquito saliva 
potentiates flavivirus infection in both in vitro and in vivo models (Conway et al., 2014), 
however it remains unknown as to whether saliva from different species differentially potentiates 
infection. 
The present study attempts to determine whether saliva from different mosquitoes can 
differentially potentiate infection. SGE extracted from different mosquito species and mixed with 
WNV was used to inoculate Vero E6 Cells. Different concentrations of SGE was first used to 
determine whether it affected the timeline of cytopathic effect. This was then followed by 
comparing SGE from different species and whether it potentiated infection determined through 
plaque assay. 
Understanding whether saliva from different species differentially potentiates infection 
allows researchers to focus vaccine development efforts. Traditionally, flavivirus vaccine 
development has targeted viral antigens, however recent vaccines designed to target arthropod 
salivary gland components have shown potential (Titus et al., 2006). By identifying species 
specific salivary factors that are implicated as primary contributors in potentiating infection, 
better multi- subunit vaccines can be made.   
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2.3 Methods 
 
2.3.1 Mosquitoes 
  Culex pipiens f. molestus, Aedes aegypti, and Aedes albopictus colony mosquito eggs 
were obtained from Rutgers University. Eggs were hatched and the larvae reared in tray filled 
with dechlorinated tap water at 28°C ± 1°C with a photoperiod of 16:8 hours light dark cycle. 
Larvae were maintained on a larval diet consisting of ground Tetramin™ fish food and brewer’s 
yeast, with the water being changed daily (Appendix). Pupae were then sorted and placed into 
emergence tanks. Newly emerged adult mosquitoes were then separated and placed in cages at 
28°C ± 1°C with a photoperiod of 16:8 hours light dark cycle at 75% ± 5 % humidity. Adults 
were maintained on 10% sucrose (Appendix) soaked cotton pads changed daily.  
 
2.3.2 Salivary Gland Dissection 
  Approximately 3-5 day old mosquitoes were used for salivary gland dissection. Salivary 
gland dissections were performed on a glass microscope slide place atop a chill table (BioQuip, 
United States) and viewed under a dissecting microscope (Leica, Germany). A drop of phosphate 
buffered saline (PBS) (Agbulos et al., 2016) was placed between the head and thorax to prevent 
desiccation during dissection. The head was gently pulled away from the body while pressure 
was applied to the thorax, revealing a pair of salivary glands. The glands were gently teased 
away from the head using fine probes and transferred in to a micro centrifuge tube filled with 
PBS on ice. Stock solutions of salivary gland extract (SGE) were made to a ratio of 1 salivary 
gland pair per 10 ul PBS. The sample solution was quickly freeze/ thawed 3 times, then 
centrifuged at 15,000 g for 5 minutes. The contents were then transferred to a 1.2 ml Corning 
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cryogenic vial, quickly frozen in liquid nitrogen and stored at -80˚C until needed. Human saliva 
was processed similarly to mosquito SGE. 
 
2.3.3 Virus 
  The WN-NY99 was used to infect Vero E6 cells. WN-NY99 strain was obtained from 
The National Microbiology Laboratory (Winnipeg, MB, CAN) on behalf of the Public Health 
Agency of Canada. Stock titre of ZIKV used was 106 PFU.  WN-NY99 was derived from a dead 
Chilean flamingo at the Bronx Zoo, New York, United States (Lanciotti et al., 1999). It was later 
isolated and passaged (p2) in Vero E6 cells. The stock titre of WNV used was 106 PFU. All virus 
concentrations were determined through plaque assay.  
 
2.3.4 Cytopathic Effect Assay 
  To help initially determine whether differences in salivary concentrations contributed to 
cytopathic effects, Vero E6 cells were plated onto 6-well plates (Sarstedt, Germany) and 
maintained with culture media (Dulbecco's Modified Eagle Medium (DMEM) High Glucose 
high glucose supplemented with 10% Fetal bovine serum (FBS) and 1% Penicillin Streptomycin 
L-Glutamine (PSG), which was adapted from Eagle, 1995 (Agbulos et al., 2016). Cells were 
inoculated with mosquito SGE and virus once confluency reach >90%. Prior to inoculation, 
media within each well was removed, and cells were gently washed with warmed (37°C) PBS. 
Ten-fold serial dilutions of SGE were prepared up to a dilution of factor (d.f.) of 100. 
Inoculations were carried out as described below:  
Well 1 (top left): 90 µL of stock SGE and 10 µL of stock WNV. Well 2 (top middle): 90 µL of 
dilution factor (d.f.) 10 SGE and 10 µL of stock WNV. Well 3 (top right): 90 µL of d.f 100 SGE 
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and 10 µL stock WNV. Well 4 (bottom left): 90 µL of stock human saliva and 10 µL of stock 
WNV. Well 5 (bottom middle): 100 µL of sterile PBS. Well 6 (bottom right): 90 µL of sterile 
PBS and 10 µL of stock WNV.Cells were left with the inoculum for 30 minutes at 37°C, with the 
plates being rocked every 10 minutes. After 30 minutes, the inoculum was removed from each 
well and 2 mL of culture media was added. Cells were observed for cytopathic effect for 5 days.  
 
2.3.5 SGE Treatment Plaque Assay 
Vero E6 cells were plated onto 6-well plates (Sarstedt, Germany) and maintained with 
culture media (DMEM high glucose supplemented with 10% FBS and 1% PSG). Cells were 
inoculated with mosquito SGE and virus once confluency reach >90%. Prior to inoculation, 
media within each well was removed, and cells were washed gently with warmed (37°C) PBS. 
SGE in a 1:1 ratio with PBS was used. Inoculations were carried out as described below:  
Wells 1 (top left) and 4 (bottom left) were each inoculated with 499 µL of 106 PFU WNV and 1 
uL of Ae. aegypti SGE. Wells 2 (top middle) and 5 (bottom middle) were inoculated with 499 uL 
106 PFU WNV and 1 uL of Ae. albopictus SGE. Well 3 (top right) was inoculated with 500 uL 
of prepared media acting as the negative control Well 6 (bottom right) was inoculated with 499 
uL of 106 PFU WNV and 1 uL of PBS acting as the positive control.  
Plates were incubated for 1 hour at 37°C, 5% CO2, being shaken every 15 minutes 
(n=20). After 1 hour, the inoculum was removed, washed with PBS, and covered with 2 mL of a 
1:1 2% DMEM and 3.4% Carboxymethyl cellulose (CMC) warmed, overlay solution (Agbulos 
et al., 2016). The plate was incubated at 37°C, 5% CO2 for 4 days. The overlay was removed and 
the cells were gently washed with warmed PBS. Each well received 1 mL of crystal violet 
staining solution and were plates were left for 30 minutes (Agbulos et al., 2016). Staining 
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solution was then removed and the wells were rinsed with warm water to reveal plaques which 
were counted after drying. 
 
2.3.6 Sodium Dodecyl Sulfate - Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
  A modified SDS- PAGE was performed based on the method of Laemmli (1970) using 
12% Mini PROTEAN TGX Precast Gels (Bio- Rad). To prepare samples for loading, 13 µl of 
salivary gland extract was mixed with 27 µl of SDS – PAGE sample buffer (Appendix). Samples 
were initially heated to 95˚C using a Mastercycler Thermocycler (Eppendorf, United States), 
then cooled to room temperature prior to loading. PageRuler Prestained Protein Ladder (Thermo 
Fisher Scientific, United States) was loaded alongside the samples. Approximately 10 µl of 
ladder and 26 µl of sample were loaded into the gel wells. The gels were electrophoresed at 200 
V continuously until the dye front and ladder reached the end of the gel. After electrophoresis, 
the gels were then stained using ProtoBlue Safe Colloidal Coomassie G-250 stain following the 
manufacturer’s instruction (National Diagnostics, England) Newly stained gels were 
photographed and visualized using the Gel Doc EZ Imager (Bio-Rad, United States). Protein 
bands were analyzed and annotated using the software Image Lab to determine the molecular 
weight of each band in kDa (Bio-Rad). 
 
2.4 Results 
 SGE from Cx. pipiens molestus, Ae. aegypti, and Ae. albopictus was isolated from 
dissected mosquito salivary glands and the proteins visualized using SDS PAGE gel 
electrophoresis. Prominent protein bands with similar sizes were observed between Ae. aegypti 
and Ae. albopictus, with dark, thick paired bands being located at the ~150 kDa, ~40 kDa and ~ 
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22 kDa range (Figure 1A, B, and C). Cx. pipiens molestus bands were not as prominent, with 
banding patterns (Figure 1C) not matching across all three species compared to both Aedes lanes. 
Numerous faint bands with various weights were noted across all three species.  
 In the cytopathic effect assays, only Cx. pipiens molestus SGE was used. Generally, 
different concentrations of SGE did not appear to accelerate cytopathic effect before 5 days when 
cells were inoculated with both virus and SGE (Figure 2). Originally out of 12 plates only 4 had 
Well 1 appeared more pink compared to Wells 2 and 3 and 6 (Figure 2). The assay was repeated 
with 8 new plates, where the Well 1 discrepancy could not be repeated and observed. 
 In the SGE Treatment plaque assays, both Ae. aegypti and Ae. albopictus SGE (1 paired 
gland per well) were used. After 4 days, wells treated with virus alone showed significantly more 
plaques (22.4 ± 0.9) than either Ae. aegypti (17.2 ± 1.4) or Ae. albopictus (14.8 ± 1.1) SGE 
treatments (Figure 3). Virus alone compared to Ae. aegypti SGE with virus treatment was 
significantly different (two sample t(23)=2.7, p= 0.01). Virus alone compared to Ae. albopictus 
SGE with virus was significantly different (two sample t(19)=4.5, p= 0.00 ). Ae. aegypti SGE 
with virus treatment compared Ae. albopictus SGE with virus treatments was not significantly 
different (two sample t(32)=1.3, p= 0.19).  
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Figure 1. SDS PAGE Gel Electrophoresis of Mosquito SGE in a 12% polyacrylamide gel. Lane 
1: PageRuler Unstained Protein Ladder (Thermo Scientific), Lane 2: Cx. pipiens molestus SGE. 
Lane 3: Ae.aegypti SGE. Lane 4: Ae. albopictus SGE. Lane 5: Human saliva. Lanes 3 and 4 
observed to be very similar compared to Lane 2. Common prominent bands located around 150 
(a), 40 (b) and 22 (c) kDa range. Multiple smaller bands not shared among the 3 mosquito lanes 
were also observed. 
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Figure 2. Vero Cells Treated with Serial Dilutions of Cx. pipiens molestus SGE and WNV. Well 
1: 90 µL of stock SGE and 10 µL of stock WNV. Well 2: 90 µL of dilution factor (d.f.) 10 SGE 
and 10 µL of stock WNV. Well 3: 90 µL of d.f 100 SGE and 10 µL stock WNV. Well 4: 90 µL 
of stock human saliva and 10 µL of stock WNV. Well 5: 100 µL of sterile PBS. Well 6: 90 µL of 
sterile PBS and 10 µL of stock WNV. Portion of plates (n=20) represented after 5 days post 
infection (d.p.i.). Cytopathic effect visualized by yellow colour. It was observed that Well 1 for 
some plates (Figure 2 A, C, D, and E) showed less cytopathic effect then Wells 2, 3 and 6 
(Figure 2 B and F).  
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Figure 3. Vero Cells Treated with either Ae. aegypti or Ae. albopictus SGE and WNV. SGE 
treatment from either species reduced the number of plaques formed when inoculated with WNV 
compared to virus alone. A Two-Tailed T-Test assuming unequal variance was used to determine 
significance. The average number of plaques found in wells inoculated with both Ae. aegypti 
SGE and WNV (n=18) was 17.2 plaques per well. The average number of plaques found in wells 
inoculated with both Ae. albopictus SGE and WNV (n=18) was 14.8 plaques per well. The 
average number of plaques found in wells incubated with WNV alone (n=9) was 22.4 plaques 
per well. Ae. aegypti wells appeared to have more plaques compared Ae. albopictus wells 
(p=0.19). Virus alone wells had significantly more plaques than both the Ae. aegypti (p=0.01) 
and Ae. albopictus (p=0.00) wells. 
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2.5 Discussion 
Our goal was to determine whether there was a differential potentiation of WNV in vitro 
using SGE from different mosquito species. Differences in observed proteins found in SGE 
between different species was expected, as Cx. pipiens molestus was less related than both Aedes 
species used, thus having a different profile of SGE proteins (Figure 1). This is most likely due 
to salivary proteins being more related between species in the same genus rather then across 
genera. Slight differences in weights can be attributed to differences in protein processing such 
as glycosylation patterns.When comparing the gel results to literature, there are differences in 
bands observed, specifically number, intensity, and location of. This can be attributed to 
differences in protocols such as salivary gland dissection/ preparation, SDS PAGE running 
conditions, or to a lesser extent innate differences in the sialome of different lab colonies used 
(Almeras et al., 2010; Arca et al., 2007).  
Our results suggest that mosquito saliva in various concentrations did not appear to alter 
when cytopathic effect in vitro occurred after (Figure 2). Discrepancies in 4 plates (n=12) 
showed that the highest concentration of Cx. pipiens molestus SGE mixed with virus resembled 
negative control more so than the positive control, appearing to exert a protective effect. A new 
experimental replicate (n=8) could not repeat the previous results and thus the discrepancy could 
not be explained.   
Our results suggest SGE from uninfected Aedes mosquitoes seem to reduce the number 
of plaques formed in plaque assay when mixed with WNV when compared to WNV alone. We 
showed that both Ae. aegypti or Ae. albopictus SGE mixed with WNV resulted in fewer plaques 
(17.2 and 14.8 plaques respectively), compared to the WNV treatment alone (24.4 plaques) 
(Figure 3). No significant difference was found when comparing the effect of Ae. aegypti versus 
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Ae. albopictus SGE (p=0.19), however both SGE treatments were significantly different 
compared to control (p= 0.01 and p=0.0002) (Figure 3). While minor differences in plaques can 
be attributed to differences in SGE between mosquito species, the protective effect differs from 
literature.  
Numerous studies have found that both in vivo and in vitro, mosquito saliva did 
positively potentiate infection. In vivo studies using a variety of animals and different viruses 
noted increases in viremia and mortality (Cox et al., 2012; Schmid et al., 2016; Schneider and 
Higgs, 2008; Schneider et al., 2007; Styer et al., 2011). Conway et al. (2014) found that the 
serine protease activity of SGE mediates infection in vitro by increasing surface attachment of 
DENV to mouse embryonic fibroblast cells (MEF) by proteolyzing the cellular matrix. Few 
studies have shown the potential protective effect of insect saliva. Reisen et al. (2000) showed 
that chickens infected with SLEV via syringe inoculation responded with a higher immune 
response, detected with enzyme immunoassay and plaque reduction neutralization tests, 
compared to infective mosquito bite. In vivo models using Malaria and Leishmaniasis parasites 
(Donovan et al., 2007; Kamhawi et al., 2000) showed that the protective effect mosquito saliva 
seems to induce is linked host immunomodulatory changes (Donovan et al., 2007). The 
protective effects of mosquito saliva may have been selected over time as a mechanism for 
Flaviviruses to infect but not kill hosts, increasing its fitness. 
A component of SGE from uninfected mosquitoes may play a role in reducing the 
virulence of WNV infection in vitro. Mosquitoes that naturally acquire viral infections mediate 
an immune response that can lead to the upregulated expression of antimicrobial peptides (Xi et 
al., 2008). These defenses are maintained at a basal level even when no infection is present. 
Girard et al. (2010) showed that Cx. quinquefasciatus infected with WNV had an increase in 
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transcript levels associated with immunity, transcription and cellular detoxification and decreases 
associated with salivary gland proteins and D7 protein family members. Xi et al. (2008), also 
noted a reduction in the AMP SRPN10A (serpin) in infected mosquito midguts. Mixing WNV 
and SGE from uninfected mosquitoes may alter potentiation due to levels of AMP SRPN10A 
present, thus hindering the virulence of WNV. Differences in when SGE is added may play a 
role in affecting potentiation. Some studies inoculate SGE first and then add the virus after a 
waiting period (Conway et al., 2014). Perhaps mixing SGE with virus initially makes WNV less 
likely to attach to mammalian cells in vitro. Using DENV and SGE from both Ae. aegypti and 
Ae. polynesiensis (Marks), Cao-Lormeau (2009) found that several SGE proteins could bind to 
DENV. WNV mixed with SGE may be inhibited from future receptor attachment due to being 
competitively bound with pre-existing SGE proteins. 
Although some mosquito salivary proteins have been characterized since their discovery, 
hundreds remain unstudied. These unknown proteins may be involved in the potentiation of viral 
infection as well as exerting protective effects. Future research into differences in interspecies 
shared salivary gland proteins as well as unique proteins will help elucidate their role in 
potentiating viral infection both in vivo and in vitro. Furthermore, comparative studies using 
saliva from a variety of mosquitoes as well as different viruses should be implemented to better 
understand specific protein roles. Multi-subunit vaccine research focusing on proteins that may 
be responsible for inducing protective effects is counterproductive.  
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Chapter 3 
Zika Virus: Quantification, Propagation, Detection, and Storage 
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Chapter 4 
The Vector Competence of Canadian Mosquitoes to Zika Virus 
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4.1 Abstract 
Zika Virus (ZIKV), belonging to the family Flaviviridae, genus Flavivirus, is an 
arthropod-borne virus that has been implicated in inducing teratogenic effects and 
neurodegenerative disease in humans. First discovered in Uganda in 1947, it had slowly spread 
throughout Southeast Asia before being detected again in Brazil in 2014. Spread by mosquitoes, 
ZIKV has rapidly spread throughout the Americas, with multiple species being implicated as 
vectors. Most positive cases of Zika in Canada are travel related and some sexually transmitted, 
with no locally acquired cases being reported. Whether or not Canadian mosquitoes are able to 
spread Zika virus remains unanswered. By orally infecting wild caught mosquitoes with a ZIKV 
infected sugar meal and detecting the presence of virus 10 and 14 days post infection (d.p.i.), the 
vector competence of Canadian mosquitoes was evaluated. It was found that after 10 (n=50) and 
14 d.p.i. (n=32), 2% and 0% of a population of Culex pipiens mosquitoes were found to be able 
to become infected and transmit the virus, respectively. Although Culex pipiens mosquitoes from 
the Niagara region may not be vectors of ZIKV, that does not negate other Canadian mosquitoes 
as being potential vectors. 
 
4.2 Introduction 
Zika virus (ZIKV; family Flaviviridae, genus Flavivirus) is an enveloped, positive-sense, 
single-stranded RNA virus that is transmitted to humans primarily by mosquitoes. Originally 
discovered in the forests of Uganda (Dick et al., 1952), ZIKV was largely ignored due to its 
rarity and non-fatal induced symptoms. Endemic to Africa, ZIKV spread throughout Asia 
eventually reaching Southeast Asian peninsulas (Jan et al., 1978; Olsen and Ksiazek, 1981; 
Robin et al., 1975). Outbreaks in Yap Island and the French Polynesian Islands prompted 
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increased surveillance of ZIKV as the severity of symptoms and frequency of human infection 
were slowly increasing (Duffy et al., 2009). ZIKV successfully traversed to the Western 
hemisphere sometime in 2014, initially being found in Brazil (Campos et al., 2015; Zanluca et 
al., 2015). Recently, ZIKV has spread throughout the Americas causing panic due to the 
perceived threat that it was able to induce both teratogenic effects and neurodegenerative disease. 
The rapid spread of ZIKV is arguably due to local and invasive mosquito species being 
competent vectors. Like most mosquito associated flaviviruses, viral replication is dependent on 
the mosquito host. If permissive to infection, ZIKV can disseminate to the salivary glands of a 
mosquito where it can be transmitted during the next blood feeding. The origin and early spread 
of ZIKV throughout Africa and Asia has largely implicated Aedes mosquitoes as the primary 
vectors (Macnamara, 1954; Marchette et al., 1969) so research has disproportionately been 
focused on the two most common Aedes species: Aedes aegypti and Aedes albopictus. While 
found throughout the Americas, the two are largely contested to be the only vectors of ZIKV. As 
ZIKV spreads throughout the Americas, Canada has yet to establish whether native populations 
of mosquitoes are competent vectors. To determine the vector competency of Canadian 
mosquitoes with regards to ZIKV, local mosquito populations need to be caught and infected. 
We analyzed the vector competency of Canadian mosquitoes by orally introducing virus through 
an infective sugar meal and tested for its presence 10 and 14 days post infection (d.p.i.) with 
qRT-PCR. Understanding which mosquito species are implicated in transmitting ZIKV will help 
better prepare Canada's response. More accurate forecasting models can be made that will better 
predict when and where outbreaks will occur. Knowing which species are implicated will also 
allow better targeted control efforts to help reduce the likelihood of spreading. 
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4.3 Methods 
 
4.3.1 Collection and Rearing 
  Wild Culex mosquitoes were collected 4 days a week during the month of August 2016 
from 9 collection sites within the Niagara region (Appendix). Both mosquito larvae/pupae and 
Culex egg rafts were collected using a larval dipper (BioQuip). Mosquito eggs and larvae were 
reared to adulthood in standard conditions (See Chapter Two).  
 
4.3.2 Virus 
The Thai 2013 ZIKV strain obtained from The National Microbiology Laboratory 
(Winnipeg, MB, CAN) on behalf of the Public Health Agency of Canada, was used to infect the 
mosquitoes. The viral strain was derived from the urine of a female tourist visiting Thailand 
(Fonseca et al., 2014). It was later isolated and passaged 5 times (p5) in Vero E6 cell line (p43) 
and suspended with 20% fetal bovine serum (FBS). Stock titre used was 106 PFU. 
 
4.3.3 Oral Infection of Mosquitoes 
  Prior to infection, adult mosquitoes were deprived and starved for 24hrs from both water 
and sucrose solutions. Approximately 3 to 5 day old female mosquitoes (n=120) were sorted, 
split and transferred into 3 sealed 0.25 L containers. Cotton pads soaked with a viral sugar 
solution (Appendix) were placed on top of each container for the mosquitoes to feed on. The 
solution was pre-warmed to 37 degrees Celsius before saturating the cotton pad. Mosquitoes fed 
for 30 minutes before being cold anaesthetized. Fully engorged females were collected and 
transferred to new 0.25 L sealed containers and 28°C ± 1°C with a photoperiod of 16h:8h light: 
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dark cycle at 75% ± 5 % humidity. Mosquitoes were provided with 10% sucrose soaked cotton 
pads changed daily (Appendix). All experiments were carried out in a containment level 3 (CL3) 
facility.   
 
4.3.4 Mosquito Processing 
  To determine ZIKV infection, dissemination, and transmission rates, mosquitoes were 
dissected after 10 and 14 days post infection (dpi). Surviving orally infected mosquitoes were 
cold anaesthetized, individually sorted, and identified to species individually using a 
photographic key (Thielman and Hunter, 2007). Legs and wings were removed and suspended in 
500 µL of mosquito diluent solution (Appendix). Saliva was then collected from the amputated 
mosquito as previously described with modification (Anderson et al., 2010). The proboscis of the 
mosquito was inserted into a capillary tube containing 5 µL of mosquito saliva collection 
solution (Appendix). Approximately 1 µL of a 1% pilocarpine solution being applied to the 
thorax to induce salivation (Dubrulle et al., 2009). After 30 minutes of salivation, the mosquito 
was removed from the capillary tube and the body suspended in 500 µL of mosquito diluent 
solution. The contents of the capillary tube post salivation were expelled and collected in 300 µL 
of mosquito diluent solution. The process was repeated for each individual mosquito. Mosquito 
body and leg/wing samples were later homogenized for RNA extraction (Appendix). To test the 
validity of the feeding method, newly fed mosquitoes (0 d.p.i.) (n=13) were sorted and frozen at -
80 degrees Celsius in 500 µL of mosquito diluent solution. Their whole body was later 
homogenized for RNA extraction. 
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4.3.5 Quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR) assay 
  Total RNA was isolated from body, leg/wing, and saliva samples using the Total RNA 
Purification Kit (Norgen, Canada) following manufacturer's recommendations. ZIKV in all 3 
samples was detected using a one-step real-time reverse transcriptase-polymerase chain reaction 
(qRT-PCR) as previously described with modification (Agbulos et al., 2017; Lancotti et al., 
2008). 
 
4.3.6 Data Analysis 
  Each mosquito yielded 3 samples: the body, leg/wing, and saliva. Infection rate (IR) was 
determined by the percentage of ZIKV positive body samples. Dissemination rate (DR) was then 
determined by the percentage of ZIKV positive leg/wing samples derived from mosquitoes 
whose bodies tested positive. Transmission rate was determined by the percentage of ZIKV 
positive saliva samples derived from mosquitoes whose body and leg/wing tested positive. 
Transmission efficiency (TE) was determined by the percentage of mosquitoes that tested 
positive for all 3 samples. Mosquitoes could transmit the virus only if it tested positive 
sequentially from body, to leg/wing, to finally saliva. Mosquito body samples that tested 
negative, negated the result of the other two samples, omitting it from further analysis.  
 
4.4 Results 
  Female mosquitoes used in the experiment were identified to be exclusively Culex 
pipiens. All 0 d.p.i. mosquitoes tested positive for ZIKV (Appendix). After 10 d.p.i., 50 
mosquitoes were dissected and subjected to qRT-PCR. Out of the 50 mosquitoes, 7 mosquito 
bodies tested positive (IR=14.00%) for ZIKV (Table 1). From the 7, only 1 leg/wing sample 
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tested positive (DR=14.29%) for ZIKV. The lone mosquito whose body and leg/wing samples 
that tested positive for ZIKV also tested positive for its saliva sample (TR=100%). Out of the 
original 50 mosquitoes, only 1 tested positive for all three (TE=2.00%)  
After 14 d.p.i., 32 mosquitoes were dissected and subjected to qRT-PCR. Out of the 32 
mosquitoes, 1 mosquito body tested positive (IR=3.10%) for ZIKV (Table 1). The lone mosquito 
tested negative for both leg/wing and saliva samples (DR and TR=0%). Out of 32 mosquitoes, 
none had disseminated nor transmitted the virus (TE=0%)  
  
Table 1. Infection, dissemination, transmission rates and efficiency for Culex pipiens molestus 
orally fed ZIKV and reared at 28°C at 10 and 14 days post infection (d.p.i.).  n= 50 after 10 d.p.i. 
and n= 32 after 14 d.p.i. Two tailed Fisher exact test used. 
 
4.5 Discussion 
Our goal was to determine the vector competence of Canadian mosquitoes to ZIKV. Our 
results suggest that female Culex pipiens mosquitoes from the Niagara region are poor vectors of 
ZIKV. We showed that after both 10 and 14 d.p.i., the IR, DR, TR, and TE were either low or 
non-existent. Low IRs after 10 and 14 d.p.i. limited the likelihood that the virus was capable of 
progressing to dissemination and transmission (Table 1). It appeared that longer incubation 
periods in the mosquitoes resulted in reduced vector competency as 14 d.p.i. mosquitoes had no 
 10 d.p.i. 14 d.p.i. p 
Infection Rate (IR) 14.00% 
(7/50)  
3.10% 
(1/32) 
0.1409 
Dissemination Rate (DR) 14.29% 
(1/7) 
0% 
(0/1) 
1.000 
Transmission Rate (TR) 100% 
(1/1) 
0% 1.000 
Transmission Efficiency (TE)  2.00% 
(1/50) 
0% 1.000 
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DR, TR and TEs while 10 d.p.i. mosquitoes had a higher IR, suggesting the clearance of virus 
from the mosquito host due to the mosquito immune response (Guo et al., 2016; Salazar et al., 
2007). 
  Similar findings using laboratory colony and wild caught Cx. pipiens, Cx. tarsalis and 
Cx. quinquefasciatus mosquitoes suggest that Culex mosquitoes are poor vectors in general 
(Aliota et al., 2016; Amraoui et al., 2016; Boccolini et al., 2016; Fernandes et al., 2016; Huang 
et al., 2016; Weger-Lucarelli et al., 2016). Their generally ornithophilic feeding behaviour 
(Magnarelli, 1977) paired with the association of Aedes mosquitoes and ZIKV furthers the 
assumption. While few, there also exists conflicting evidence suggesting that Cx. 
quinquefasciatus is a capable vector (Guedes et al., 2016, Guo et al., 2016). Not to be excluded, 
Culex mosquitoes have been hypothesized to be implicated in the transmission of ZIKA in some 
capacity. The reassignment of ZIKV from hemorrhagic/ Aedes-associated virus to neurotrophic/ 
Culex-associated virus increases the possibility that one or more unknown Culex species may be 
a vector (Leal, 2016). Recent forecasting models even predict other lesser known Culex species 
to play a role in transmission (Evans et al., 2016). Ambiguity in the vector competence of 
commonly tested Culex species hints at the possibility of innate differences between laboratory 
colonized and wild caught mosquito populations that dictate permissiveness to ZIKV infection. 
Observed in both laboratory and wild mosquito populations with various flaviviruses, these 
innate differences have been linked to genetics and/ or the presence of pathogens within the 
mosquito interfering with infection (Bolling et al., 2015; Gubler et al., 1979; Hardy et al., 1976). 
  Discrepancies in vector competency status may also arise from differences in the virus 
used. The spread of ZIKV from Uganda to the Americas has produced numerous strains which 
have been employed by many researchers which have also been fed to mosquitoes in various 
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concentrations (Aliota et al., 2016; Amraoui et al., 2016; Boccolini et al., 2016; Fernandes et al., 
2016; Guedes et al., 2016, Guo et al., 2016; Huang et al., 2016; Weger-Lucarelli et al., 2016). 
Differences in virulence has been noted between strains both in vivo and in vitro (Simionin et al., 
2016; Stauft et al., 2016. Weger-Lucarelli et al., 2016). Although this study could not 
successfully infect mosquitoes as others have, the similar strains of virus and concentrations used 
have previously been used to successfully infect (Guedes et al., 2016, Guo et al., 2016). 
  The method of feeding used in this study may have altered the results; compared to every 
other study in which mosquitoes have been infected with ZIKV suspended in blood, this study 
used ZIKA in a sucrose meal. Aragão (1922) first successfully infected male Aedes aegypti 
mosquitoes with YFV in a honey/ blood suspension when it was only assumed that females 
could be infected. Proof of concept showed that virus was found 0 d.p.i. in whole mosquitoes and 
that infected bodies were still found 10 and 14 d.p.i suggesting its usefulness in some capacity. 
WNV had been previously used to successfully infect both Aedes aegypti and Aedes albopictus 
in similar fashion further suggesting its use as a viable alternative to blood (Causarano, 2017). 
  Since there is no consensus from the scientific community on the vector competence 
status of mosquitoes and ZIKV, these findings only contribute to the growing need for future 
research. It is widely assumed that the principle vectors of ZIKV are mosquitoes belonging to the 
Aedes genus, subgenus Stegomyia, with emphasis on Ae. aegypti and Ae. albopictus, although 
other studies indicate that species from other genera most likely play some role. Although Culex 
pipiens mosquitoes from the Niagara region may not be good vectors of ZIKV, that does not 
negate other Canadian mosquitoes. With the recent arrival of Ae. aegypti and Ae. albopictus in 
Canada, the vector competence status of native species may become more complicated.  
 
67 
 
Literature Cited 
Ackermann, M., & Padmanabhan, R. (2001). De novo synthesis of RNA by the dengue virus 
RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but 
not elongation phase. Journal of Biological Chemistry, 276(43), 39926-39937.  
 
Agbulos, D.S., Barelli, L., Giordano, B.V., and Hunter, F.F. (2016). Zika Virus: Quantification, 
Propagation, Detection, and Storage. Current Protocols in Microbiology, 15D. 14.11-
15D. 14.16. 
 
Aliota, M. T., Peinado, S. A., Osorio, J. E., & Bartholomay, L. C. (2016). Culex pipiens and 
 Aedes triseriatus mosquito susceptibility to Zika virus. Emerging Infectious Diseases, 
 22(10), 1857.  
 
Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W., & Heinz, F. X. (2001). Mutational 
evidence for an internal fusion peptide in flavivirus envelope protein E. Journal of 
Virology, 75(9), 4268-4275.  
 
Almeras, L., Fontaine, A., Belghazi, M., Bourdon, S., Boucomont-Chapeaublanc, E., Orlandi-
Pradines, E., . . . Pradines, B. (2010). Salivary gland protein repertoire from Aedes 
aegypti mosquitoes. Vector-Borne and Zoonotic Diseases, 10(4), 391-402.  
 
Amberg, S. M., & Rice, C. M. (1999). Mutagenesis of the NS2B-NS3-mediated cleavage site in 
the flavivirus capsid protein demonstrates a requirement for coordinated processing. 
Journal of Virology, 73(10), 8083-8094.  
 
Amraoui, F., Atyame-Nten, C., Vega-Rúa, A., Lourenço-de-Oliveira, R., Vazeille, M., & 
Failloux, A. B. (2016). Culex mosquitoes are experimentally unable to transmit Zika 
virus. Eurosurveillance, 21(35).  
 
Anderson, S. L., Richards, S. L., & Smartt, C. T. (2010). A simple method for determining 
arbovirus transmission in mosquitoes. Journal of the American Mosquito Control 
Association, 26(1), 108.  
 
Aragão, H. d. B. (1929). On infection of the male Aedes aegypti and the possibility of 
propagation of yellow fever from Stegomyia to Stegomyia without passage through man. 
Mem Inst Oswaldo Cruz, 22, 190-195.  
 
Arcà, B., Lombardo, F., de Lara Capurro, M., Della Torre, A., Dimopoulos, G., James, A. A., & 
Coluzzi, M. 1999. Trapping cDNAs encoding secreted proteins from the salivary glands 
of the malaria vector Anopheles gambiae. Proceedings of the National Academy of 
Sciences, 96(4), 1516-1521. 
 
Arcà, B., Lombardo, F., Francischetti, I.M., Pham, V.M., Mestres-Simon, M., Andersen, J.F., 
 and Ribeiro, J.M. (2007). An insight into the sialome of the adult female mosquito Aedes 
 albopictus. Insect biochemistry and molecular biology 37, 107-127. 
68 
 
 
Austgen, L. E., Bowen, R. A., Bunning, M. L., Davis, B. S., Mitchell, C. J., & Chang, G. (2004). 
Experimental infection of cats and dogs with West Nile virus. Emerging Infectious 
Diseases, 10(1), 82-86.  
 
Bakonyi, T., Hubálek, Z., Rudolf, I., & Nowotny, N. (2005). Novel flavivirus or new lineage of 
West Nile virus, central Europe. Emerg Infect Diseases, 11(2), 225-231.  
 
Bernard, K. A., Maffei, J. G., Jones, S. A., Kauffman, E. B., Ebel, G., Dupuis 2nd, A., . . . Shi, 
P.-Y. (2001). West Nile virus infection in birds and mosquitoes, New York State, 2000. 
Emerging Infectious Diseases, 7(4), 679.  
 
Berthet, F., Zeller, H., Drouet, M., Rauzier, J., Digoutte, J., & Deubel, V. (1997). Extensive 
nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African 
West Nile viruses. Journal of General Virology, 78(9), 2293-2297.  
 
Bhuvanakantham, R., Cheong, Y. K., & Ng, M.-L. (2010). West Nile virus capsid protein 
interaction with importin and HDM2 protein is regulated by protein kinase C-mediated 
phosphorylation. Microbes and Infection, 12(8), 615-625.  
 
Blackwell, J. L., & Brinton, M. A. (1995). BHK cell proteins that bind to the 3'stem-loop 
structure of the West Nile virus genome RNA. Journal of Virology, 69(9), 5650-5658.  
 
Blackwell, J. L., & Brinton, M. A. (1997). Translation elongation factor-1 alpha interacts with 
the 3'stem-loop region of West Nile virus genomic RNA. Journal of Virology, 71(9), 
6433-6444.  
 
Boccolini, D., Toma, L., Di Luca, M., Severini, F., Romi, R., Remoli, M. E., . . . Fortuna, C. 
(2016). Experimental investigation of the susceptibility of Italian Culex pipiens 
mosquitoes to Zika virus infection. Eurosurveillance, 21(35).  
 
Boege, U., Heinz, F. X., Wengler, G., & Kunz, C. (1983). Amino acid compositions and amino-
terminal sequences of the structural proteins of a flavivirus, European tick-borne 
encephalitis virus. Virology, 126(2), 651-657.  
 
Bolling, B. G., Vasilakis, N., Guzman, H., Widen, S. G., Wood, T. G., Popov, V. L., . . . Tesh, R. 
B. (2015). Insect-specific viruses detected in laboratory mosquito colonies and their 
potential implications for experiments evaluating arbovirus vector competence. The 
American journal of tropical medicine and hygiene, 92(2), 422-428.  
 
Brault, A. C., Huang, C. Y., Langevin, S. A., Kinney, R. M., Bowen, R. A., Ramey, W. N., . . . 
Miller, B. R. (2007). A single positively selected West Nile viral mutation confers 
increased virogenesis in American crows. Nature genetics, 39(9), 1162-1166.  
 
69 
 
Brault, A. C., Langevin, S. A., Bowen, R. A., Panella, N. A., Biggerstaff, B. J., Miller, B. R., & 
Komar, N. (2004). Differential virulence of West Nile strains for American crows. 
Emerging Infectious Diseases, 10(12), 2161.  
 
Bressanelli, S., Stiasny, K., Allison, S. L., Stura, E. A., Duquerroy, S., Lescar, J., . . . Rey, F. A. 
(2004). Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane 
fusion conformation. The EMBO Journal, 23(4), 728-738.  
 
Brinton, M. A. (2002). The molecular biology of West Nile Virus: a new invader of the western 
hemisphere. Annual Reviews in Microbiology, 56(1), 371-402.  
 
Brinton, M. A., & Dispoto, J. H. (1988). Sequence and secondary structure analysis of the 5′-
 terminal region of flavivirus genome RNA. Virology, 162(2), 290-299.  
 
Bulich, R., & Aaskov, J. (1992). Nuclear localization of dengue 2 virus core protein detected 
with monoclonal antibodies. Journal of General Virology, 73(11), 2999-3003.  
 
Bunning, M. L., Bowen, R. A., Cropp, C. B., Sullivan, K. G., Davis, B. S., Komar, N., . . . 
Holmes, D. A. (2002). Experimental infection of horses with West Nile virus. Emerging 
Infectious Diseases, 8(4), 380-386.  
 
Cahour, A., Pletnev, A., Vazeille-Falcoz, M., Rosen, L., & Lai, C.-J. (1995). Growth-restricted 
dengue virus mutants containing deletions in the 5′ noncoding region of the RNA 
genome. Virology, 207(1), 68-76.  
 
Campbell, G. L., Ceianu, C. S., & Savage, H. M. (2001). Epidemic West Nile Encephalitis in 
Romania. Annals of the New York Academy of Sciences, 951(1), 94-101.  
 
Campos, G. S., Bandeira, A. C., & Sardi, S. I. (2015). Zika virus outbreak, Bahia, Brazil. 
Emerging Infectious Diseases, 21(10), 1885.  
 
Cao-Lormeau, V.M. (2009). Dengue viruses binding proteins from Aedes aegypti and Aedes 
polynesiensis salivary glands. Virol J 6, 35. 
 
Cao-Lormeau, V.-M., Blake, A., Mons, S., Lastère, S., Roche, C., Vanhomwegen, J., . . . Larre, 
P. (2016). Guillain-Barré Syndrome outbreak associated with Zika virus infection in 
French Polynesia: a case-control study. The Lancet, 387(10027), 1531-1539.  
 
Causarano, J. (2017). Secondary Transmission Dynamics of the West Nile Virus in Mosquitoes. 
 
Cervantes-Salazar, M., Angel-Ambrocio, A.H., Soto-Acosta, R., Bautista-Carbajal, P., Hurtado-
 Monzon, A.M., Alcaraz-Estrada, S.L., Ludert, J.E., and Del Angel, R.M. (2015). Dengue 
 virus NS1 protein interacts with the ribosomal protein RPL18: this interaction is required 
 for viral translation and replication in Huh-7 cells. Virology 484, 113-126. 
 
70 
 
Chambers, T. J., McCourt, D. W., & Rice, C. M. (1990). Production of yellow fever virus 
proteins in infected cells: identification of discrete polyprotein species and analysis of 
cleavage kinetics using region-specific polyclonal antisera. Virology, 177(1), 159-174.  
 
Chambers, T. J., Nestorowicz, A., Amberg, S. M., & Rice, C. M. (1993). Mutagenesis of the 
yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex 
formation, and viral replication. Journal of Virology, 67(11), 6797-6807.  
 
Chambers, T. J., Weir, R. C., Grakoui, A., McCourt, D. W., Bazan, J. F., Fletterick, R. J., & 
Rice, C. M. (1990). Evidence that the N-terminal domain of nonstructural protein NS3 
from yellow fever virus is a serine protease responsible for site-specific cleavages in the 
viral polyprotein. Proceedings of the National Academy of Sciences, 87(22), 8898-8902.  
 
Champagne, D. E., Smartt, C. T., Ribeiro, J., & James, A. A. (1995). The salivary gland-specific 
apyrase of the mosquito Aedes aegypti is a member of the 5'-nucleotidase family. 
Proceedings of the National Academy of Sciences, 92(3), 694-698.  
 
Chang, H.-H., Shyu, H.-F., Wang, Y.-M., Sun, D.-S., Shyu, R.-H., Tang, S.-S., & Huang, Y.-S. 
(2002). Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 
(NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 
antigen. Journal of Infectious Diseases, 186(6), 743-751.  
 
Cheng, G., Cox, J., Wang, P., Krishnan, M. N., Dai, J., Qian, F., . . . Fikrig, E. (2010). A C-type 
lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus 
infection of mosquitoes. Cell, 142(5), 714-725.  
 
Christophers, S. R. (1945). Structure of the Culex egg raft and egg-raft related to function 
(Diptera). Transactions of the Royal Entomological Society of London, 95(2), 25-34.  
 
Chu, J., Leong, P., & Ng, M. (2006). Analysis of the endocytic pathway mediating the infectious 
entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) 
cells. Virology, 349(2), 463-475.  
 
Ciano, K.A., Saredy, J.J., and Bowers, D.F. (2014). Heparan sulfate proteoglycan: an arbovirus 
attachment factor integral to mosquito salivary gland ducts. Viruses 6, 5182-5197. 
 
Cleaves, G. R., & Dubin, D. T. (1979). Methylation status of intracellular dengue type 2 40 S 
RNA. Virology, 96(1), 159-165.  
 
Clements, A. (1993). The biology of mosquitoes, Vol. I; Development, nutrition and 
reproduction. Parasitology Today, 9(4), 147.  
 
Control, C. f. D., & Prevention. (1999). Outbreak of West Nile-like viral encephalitis--New 
York, 1999. MMWR. Morbidity and mortality weekly report, 48(38), 845.  
 
71 
 
Control, C. f. D., & Prevention. (2012). West nile virus disease and other arboviral diseases-
United States, 2011. MMWR. Morbidity and mortality weekly report, 61(27), 510.  
 
Conway, M. J., Watson, A. M., Colpitts, T. M., Dragovic, S. M., Li, Z., Wang, P., . . . Klimstra, 
W. B. (2014). Mosquito saliva serine protease enhances dissemination of dengue virus 
into the mammalian host. Journal of Virology, 88(1), 164-175.  
 
Cox, J., Mota, J., Sukupolvi-Petty, S., Diamond, M.S., and Rico-Hesse, R. (2012). Mosquito bite 
delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. 
Journal of Virology. 86, 7637-7649. 
 
Davis, C. W., Nguyen, H.-Y., Hanna, S. L., Sánchez, M. D., Doms, R. W., & Pierson, T. C. 
(2006). West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular 
attachment and infection. Journal of Virology, 80(3), 1290-1301.  
 
Davis, W.G., Basu, M., Elrod, E.J., Germann, M.W., and Brinton, M.A. (2013). Identification of 
cis-acting nucleotides and a structural feature in West Nile virus 3′-terminus RNA that 
facilitate viral minus strand RNA synthesis. J. Virol. 87, 7622-7636. 
 
Dick, G. (1952). Zika virus (II). Pathogenicity and physical properties. Trans R Soc Trop Med 
Hyg, 46(5), 521-534.  
 
Dick, G., Kitchen, S., & Haddow, A. (1952). Zika virus (I). Isolations and serological specificity. 
Trans R Soc Trop Med Hyg, 46(5), 509-520.  
 
Dohm, D. J., Sardelis, M. R., & Turell, M. J. (2002). Experimental vertical transmission of West 
Nile virus by Culex pipiens (Diptera: Culicidae). Journal of Medical Entomology, 39(4), 
640-644.  
 
Dong, H., Chang, D.C., Hua, M.H.C., Lim, S.P., Chionh, Y.H., Hia, F., Lee, Y.H., Kukkaro, P., 
Lok, S.-M., and Dedon, P.C. (2012). 2′-O methylation of internal adenosine by flavivirus 
NS5 methyltransferase. PLoS Pathog 8, e1002642. 
 
Dokland, T., Walsh, M., Mackenzie, J. M., Khromykh, A. A., Ee, K.-H., & Wang, S. (2004). 
West Nile virus core protein: tetramer structure and ribbon formation. Structure, 12(7), 
1157-1163.  
 
Donovan, M.J., Messmore, A.S., Scrafford, D.A., Sacks, D.L., Kamhawi, S., and McDowell, 
M.A. (2007). Uninfected mosquito bites confer protection against infection with malaria 
parasites. Infection and immunity 75, 2523-2530. 
 
Dubrulle, M., Mousson, L., Moutailler, S., Vazeille, M., and Failloux, A.-B. (2009). 
Chikungunya virus and Aedes mosquitoes: saliva is infectious as soon as two days after 
oral infection. PloS one 4, e5895. 
 
72 
 
Duffy, M. R., Chen, T.-H., Hancock, W. T., Powers, A. M., Kool, J. L., Lanciotti, R. S., . . . 
Dubray, C. (2009). Zika virus outbreak on Yap Island, federated states of Micronesia. 
New England Journal of Medicine, 360(24), 2536-2543.  
 
Eagle, H. (1955). Nutrition needs of mammalian cells in tissue culture. Science 122, 501-504. 
 
Egloff, M.-P., Decroly, E., Malet, H., Selisko, B., Benarroch, D., Ferron, F., and Canard, B. 
(2007). Structural and functional analysis of methylation and 5′-RNA sequence 
requirements of short capped RNAs by the methyltransferase domain of dengue virus 
NS5. Journal of molecular biology 372, 723-736. 
 
Eliason, D. A. (1963). Feeding adult mosquitoes on solid sugars. 
 
Enfissi, A., Codrington, J., Roosblad, J., Kazanji, M., and Rousset, D. (2016). Zika virus genome 
from the Americas. The Lancet 387, 227-228. 
 
Evans, M., Dallas, T. A., Han, B. A., Murdock, C. C., & Drake, J. M. (2016). Data-driven 
identification of potential Zika virus vectors. bioRxiv, 077966.  
 
Falconar, A. (1997). The dengue virus nonstructural-1 protein (NS1) generatesantibodies to 
common epitopes on human blood clotting, integrin/adhesin proteins and binds to 
humanendothelial cells: potential implications in haemorrhagic fever pathogenesis. 
Archives of Virology, 142(5), 897-916.  
 
Falgout, B., Chanock, R., & Lai, C. (1989). Proper processing of dengue virus nonstructural 
glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the 
downstream nonstructural protein NS2a. Journal of Virology, 63(5), 1852-1860.  
 
Falgout, B., & Markoff, L. (1995). Evidence that flavivirus NS1-NS2A cleavage is mediated by 
a membrane-bound host protease in the endoplasmic reticulum. Journal of Virology, 
69(11), 7232-7243.  
 
Falgout, B., Pethel, M., Zhang, Y., & Lai, C. (1991). Both nonstructural proteins NS2B and NS3 
are required for the proteolytic processing of dengue virus nonstructural proteins. Journal 
of Virology, 65(5), 2467-2475.  
 
Fernandes, R. S., Campos, S. S., Ferreira-de-Brito, A., de Miranda, R. M., da Silva, K. A. B., de 
Castro, M. G., . . . Bonaldo, M. C. (2016). Culex quinquefasciatus from Rio de Janeiro is 
not competent to transmit the local Zika virus. PLoS Negl Trop Dis, 10(9), e0004993.  
 
Fonseca, D. M., Keyghobadi, N., Malcolm, C. A., Mehmet, C., Schaffner, F., Mogi, M., . . . 
Wilkerson, R. C. (2004). Emerging vectors in the Culex pipiens complex. Science, 
303(5663), 1535-1538.  
 
Fonseca, D. M., Smith, J. L., Wilkerson, R. C., & Fleischer, R. C. (2006). Pathways of expansion 
and multiple introductions illustrated by large genetic differentiation among worldwide 
73 
 
populations of the southern house mosquito. The American journal of tropical medicine 
and hygiene, 74(2), 284-289.  
 
Fonseca, K., Meatherall, B., Zarra, D., Drebot, M., MacDonald, J., Pabbaraju, K., . . . Tellier, R. 
(2014). First case of Zika virus infection in a returning Canadian traveler. The American 
journal of tropical medicine and hygiene, 91(5), 1035-1038.  
 
Francischetti, I. M., Valenzuela, J. G., Pham, V. M., Garfield, M. K., & Ribeiro, J. M. (2002). 
Toward a catalog for the transcripts and proteins (sialome) from the salivary gland of the 
malaria vector Anopheles gambiae. Journal of Experimental Biology, 205(16), 2429-
2451.  
 
Franz, A. W., Kantor, A. M., Passarelli, A. L., & Clem, R. J. (2015). Tissue barriers to arbovirus 
infection in mosquitoes. Viruses, 7(7), 3741-3767.  
 
Gaunt, M. W., Sall, A. A., de Lamballerie, X., Falconar, A. K., Dzhivanian, T. I., & Gould, E. A. 
(2001). Phylogenetic relationships of flaviviruses correlate with their epidemiology, 
disease association and biogeography. Journal of General Virology, 82(8), 1867-1876.  
 
Gillett, J. (1956). Genetic differences affecting egg-laying in the mosquito Aedes (Stegomyia) 
aegypti (Linnaeus). Annals of Tropical Medicine & Parasitology, 50(4), 362-374.  
 
Giordano, B.V., Gasparotto, A., and Hunter, F.F. (2015). A checklist of the 67 mosquito species 
of Ontario, Canada. Journal of the American Mosquito Control Association 31, 101-103. 
 
Girard, Y.A., Mayhew, G.F., Fuchs, J.F., Li, H., Schneider, B.S., McGee, C.E., Rocheleau, T.A., 
Helmy, H., Christensen, B.M., and Higgs, S. (2010). Transcriptome changes in Culex 
quinquefasciatus (Diptera: Culicidae) salivary glands during West Nile virus infection. 
Journal of medical entomology 47, 421-435. 
 
Gorbalenya, A. E., Donchenko, A. P., Koonin, E. V., & Blinov, V. M. (1989). N-terminal 
domains of putative helicases of flavi-and pestiviruses may be serine proteases. Nucleic 
acids research, 17(10), 3889-3897.  
 
Gorbalenya, A. E., Koonin, E. V., Donchenko, A. P., & Blinov, V. M. (1989). Two related 
superfamilies of putative helicases involved in replication, recombination, repair and 
expression of DNA and RNA genomes. Nucleic acids research, 17(12), 4713-4730.  
 
Grard, G., Caron, M., Mombo, I. M., Nkoghe, D., Ondo, S. M., Jiolle, D., . . . Leroy, E. M. 
(2014). Zika virus in Gabon (Central Africa)–2007: a new threat from Aedes albopictus? 
PLoS Negl Trop Dis, 8(2), e2681.  
 
Grun, J. B., & Brinton, M. A. (1986). Characterization of West Nile virus RNA-dependent RNA 
polymerase and cellular terminal adenylyl and uridylyl transferases in cell-free extracts. 
Journal of Virology, 60(3), 1113-1124.  
 
74 
 
Gubler, D. J., Nalim, S., Tan, R., Saipan, H., & Sulianti, S. J. (1979). Variation in susceptibility 
to oral infection with dengue viruses among geographic strains of Aedes aegypti. The 
American journal of tropical medicine and hygiene, 28(6), 1045-1052.  
 
Guedes, D. R., Paiva, M. H., Donato, M. M., Barbosa, P. P., Krokovsky, L., Rocha, S. W. d. S., . 
. . Oliveira, C. M. (2016). Zika virus replication in the mosquito Culex quinquefasciatus 
in Brazil. bioRxiv, 073197.  
 
Guo, X.-x., Li, C.-x., Deng, Y.-q., Xing, D., Liu, Q.-m., Wu, Q., . . . Zhao, T.-y. (2016). Culex 
pipiens quinquefasciatus: a potential vector to transmit Zika virus. Emerging Microbes & 
Infections, 5(9), e102.  
 
Guyatt, K. J., Westaway, E. G., & Khromykh, A. A. (2001). Expression and purification of 
enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the 
flavivirus Kunjin. Journal of Virological Methods, 92(1), 37-44.  
 
Halstead, S. B., & Schlesinger, R. (1980). Immunological parameters of togavirus disease 
syndromes: Academic Press. New York, New York, USA. 
 
Hardy, J. L., Houk, E. J., Kramer, L. D., & Reeves, W. C. (1983). Intrinsic factors affecting 
vector competence of mosquitoes for arboviruses. Annu Rev Entomol, 28(1), 229-262.  
 
Hardy, J. L., Reeves, W. C., & Sjorgen, R. D. (1976). Variation in the susceptibility of field and 
laboratory populations of Culex tarsalis to experimental infection with western equine 
encephalomyelitis virus. American journal of epidemiology, 103(5), 498-505.  
 
Hsieh, S.-C., Zou, G., Tsai, W.-Y., Qing, M., Chang, G.-J., Shi, P.-Y., & Wang, W.-K. (2011). 
The C-terminal helical domain of dengue virus precursor membrane protein is involved 
in virus assembly and entry. Virology, 410(1), 170-180.  
 
Huang, Y.-J. S., Ayers, V. B., Lyons, A. C., Unlu, I., Alto, B. W., Cohnstaedt, L. W., . . . 
Vanlandingham, D. L. (2016). Culex species mosquitoes and Zika virus. Vector-Borne 
and Zoonotic Diseases, 16(10), 673-676.  
 
Isawa, H., Yuda, M., Orito, Y., & Chinzei, Y. (2002). A mosquito salivary protein inhibits 
activation of the plasma contact system by binding to factor XII and high molecular 
weight kininogen. Journal of Biological Chemistry, 277(31), 27651-27658.  
 
James, A., & Rossignol, P. (1991). Mosquito salivary glands: parasitological and molecular 
aspects. Parasitology Today, 7(10), 267-271.  
 
Jan, C., Languillat, G., Renaudet, J., & Robin, Y. (1978). A serological survey of arboviruses in 
Gabon. Bulletin de la Societe de Pathologie Exotique et de ses Filiales, 71(2), 140.  
 
75 
 
Jan, L.-R., Yang, C.-S., Trent, D. W., Falgout, B., & Lai, C.-J. (1995). Processing of Japanese 
encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous 
proteases. Journal of General Virology, 76(3), 573-580.  
 
Juhn, J., Naeem-Ullah, U., Guedes, B.A.M., Majid, A., Coleman, J., Pimenta, P.F.P., Akram, W., 
James, A.A., and Marinotti, O. (2011). Spatial mapping of gene expression in the salivary 
glands of the dengue vector mosquito, Aedes aegypti. Parasites & vectors 4, 1 
 
Kamhawi, S., Belkaid, Y., Modi, G., Rowton, E., and Sacks, D. (2000). Protection against 
cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 290, 1351-
1354. 
 
Kilpatrick, A. M., Kramer, L. D., Campbell, S. R., Alleyne, E. O., Dobson, A. P., & Daszak, P. 
(2005). West Nile virus risk assessment and the bridge vector paradigm. Emerg Infect 
Dis, 11(3), 425-429.  
 
Kim, Y.M., Gayen, S., Kang, C., Joy, J., Huang, Q., Chen, A.S., Wee, J.L.K., Ang, M.J.Y., Lim, 
H.A., and Hung, A.W. (2013). NMR analysis of a novel enzymatically active unlinked 
dengue NS2B-NS3 protease complex. Journal of Biological Chemistry 288, 12891-
12900. 
 
Klingberg, M., Jasinska-Klingberg, W., & Goldblum, N. (1959). Certain aspects of the 
epidemiology and distribution of immunity of West Nile virus in Israel. 
 
Kofler, R. M., Heinz, F. X., & Mandl, C. W. (2002). Capsid protein C of tick-borne encephalitis 
virus tolerates large internal deletions and is a favorable target for attenuation of 
virulence. Journal of Virology, 76(7), 3534-3543.  
 
Komar, N., Langevin, S., Hinten, S., Nemeth, N., Edwards, E., Hettler, D., . . . Bunning, M. 
(2003). Experimental infection of North American birds with the New York 1999 strain 
of West Nile virus. Emerging Infectious Diseases, 9(3), 311-322.  
 
Konishi, E., & Mason, P. (1993). Proper maturation of the Japanese encephalitis virus envelope 
glycoprotein requires cosynthesis with the premembrane protein. Journal of Virology, 
67(3), 1672-1675.  
 
Kurosu, T., Chaichana, P., Yamate, M., Anantapreecha, S., and Ikuta, K. (2007). Secreted 
complement regulatory protein clusterin interacts with dengue virus nonstructural protein 
1. Biochemical and biophysical research communications 362, 1051-1056. 
 
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature, 227, 680-685.  
 
Lanciotti, R., Roehrig, J., Deubel, V., Smith, J., Parker, M., Steele, K., . . . Scherret, J. (1999). 
Origin of the West Nile virus responsible for an outbreak of encephalitis in the 
northeastern United States. Science, 286(5448), 2333-2337.  
76 
 
 
Lanciotti, R. S., Kosoy, O. L., Laven, J. J., Velez, J. O., Lambert, A. J., Johnson, A. J., . . . 
Duffy, M. R. (2008). Genetic and serologic properties of Zika virus associated with an 
epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis, 14(8), 1232-1239.  
 
Langevin, S. A., Brault, A. C., Panella, N. A., Bowen, R. A., & Komar, N. (2005). Variation in 
virulence of West Nile virus strains for house sparrows (Passer domesticus). The 
American journal of tropical medicine and hygiene, 72(1), 99-102.  
 
Leal, W. S. (2016). Zika mosquito vectors: the jury is still out. F1000Research, 5.  
 
Leung, J.Y., Pijlman, G.P., Kondratieva, N., Hyde, J., Mackenzie, J.M., and Khromykh, A.A. 
(2008). Role of nonstructural protein NS2A in flavivirus assembly. J. Virol. 82, 4731-
4741. 
 
Li, H., Clum, S., You, S., Ebner, K.E., and Padmanabhan, R. (1999). The serine protease and 
RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of 
dengue virus type 2 NS3 converge within a region of 20 amino acids. J. Virol. 73, 3108-
3116. 
 
Li, L., Lok, S.-M., Yu, I.-M., Zhang, Y., Kuhn, R. J., Chen, J., & Rossmann, M. G. (2008). The 
flavivirus precursor membrane-envelope protein complex: structure and maturation. 
Science, 319(5871), 1830-1834.  
 
Li, W., Li, Y., Kedersha, N., Anderson, P., Emara, M., Swiderek, K., . . . Brinton, M. (2002). 
Cell proteins TIA-1 and TIAR interact with the 3′ stem-loop of the West Nile virus 
complementary minus-strand RNA and facilitate virus replication. Journal of Virology, 
76(23), 11989-12000.  
Liu, Y., Liu, H., Zou, J., Zhang, B., and Yuan, Z. (2014). Dengue virus subgenomic RNA 
induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway. Virology 448, 
15-25. 
 
Liu, W.J., Wang, X.J., Clark, D.C., Lobigs, M., Hall, R.A., and Khromykh, A.A. (2006). A 
single amino acid substitution in the West Nile virus nonstructural protein NS2A disables 
its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. 
J. Virol. 80, 2396-2404 
 
Lorenz, I. C., Allison, S. L., Heinz, F. X., & Helenius, A. (2002). Folding and dimerization of 
tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. 
Journal of Virology, 76(11), 5480-5491.  
 
Lounibos, L. P., & Kramer, L. D. (2016). Invasiveness of Aedes aegypti and Aedes albopictus 
and Vectorial Capacity for Chikungunya Virus. Journal of Infectious Diseases, 214(suppl 
5), S453-S458.  
 
77 
 
Ma, L., Jones, C. T., Groesch, T. D., Kuhn, R. J., & Post, C. B. (2004). Solution structure of 
dengue virus capsid protein reveals another fold. Proceedings of the National Academy of 
Sciences of the United States of America, 101(10), 3414-3419.  
 
Mackenzie, J. M., Khromykh, A. A., Jones, M. K., & Westaway, E. G. (1998). Subcellular 
localization and some biochemical properties of the flavivirus Kunjin nonstructural 
proteins NS2A and NS4A. Virology, 245(2), 203-215.  
 
Mackenzie, J. M., & Westaway, E. G. (2001). Assembly and maturation of the flavivirus Kunjin 
virus appear to occur in the rough endoplasmic reticulum and along the secretory 
pathway, respectively. Journal of Virology, 75(22), 10787-10799.  
 
Macnamara, F. (1954). Zika virus: a report on three cases of human infection during an epidemic 
of jaundice in Nigeria. Trans R Soc Trop Med Hyg, 48(2), 139-145.  
 
Magnarelli, L. (1977). Host feeding patterns of Connecticut mosquitoes (Diptera: Culicidae). The 
American journal of tropical medicine and hygiene, 26(3), 547-552.  
 
Marchette, N., Garcia, R., & Rudnick, A. (1969). Isolation of Zika virus from Aedes aegypti 
mosquitoes in Malaysia. American Journal of Tropical Medicine and Hygiene, 18(3), 
411-415.  
 
Markoff, L., Falgout, B., & Chang, A. (1997). A conserved internal hydrophobic domain 
mediates the stable membrane integration of the dengue virus capsid protein. Virology, 
233(1), 105-117.  
 
Mason, P. W. (1989). Maturation of Japanese encephalitis virus glycoproteins produced by 
infected mammalian and mosquito cells. Virology, 169(2), 354-364.  
 
Mattingly, P. (1967). Taxonomy of Aedes aegypti and related species. Bulletin of the World 
Health Organization, 36(4), 552.  
 
McElroy, K.L., Tsetsarkin, K.A., Vanlandingham, D.L., and Higgs, S. (2006). Manipulation of 
the yellow fever virus non-structural genes 2A and 4B and the 3′ non-coding region to 
evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut. The 
American journal of tropical medicine and hygiene 75, 1158-1164. 
 
McIntosh, B., Jupp, P., Dos Santos, I., & Meenehan, G. (1976). Epidemics of West Nile and 
Sindbis viruses in South Africa with Culex (Culex) univittatus Theobald as vector. South 
African Journal of Science, 72(10), 295-300. 
 
Melian, E.B., Hinzman, E., Nagasaki, T., Firth, A.E., Wills, N.M., Nouwens, A.S., Blitvich, B.J., 
Leung, J., Funk, A., and Atkins, J.F. (2010). NS1′ of flaviviruses in the Japanese 
encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in 
viral neuroinvasiveness. J. Virol. 84, 1641-1647. 
  
78 
 
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2004). Structure of the dengue virus 
envelope protein after membrane fusion. Nature, 427(6972), 313-319.  
 
Moon, S.L., Anderson, J.R., Kumagai, Y., Wilusz, C.J., Akira, S., Khromykh, A.A., and Wilusz, 
J. (2012). A noncoding RNA produced by arthropod-borne flaviviruses inhibits the 
cellular exoribonuclease XRN1 and alters host mRNA stability. Rna 18, 2029-2040. 
 
Muller, D.A., and Young, P.R. (2013). The flavivirus NS1 protein: molecular and structural 
biology, immunology, role in pathogenesis and application as a diagnostic biomarker. 
Antiviral research 98, 192-208. 
 
Murgue, B., Murri, S., Triki, H., Deubel, V., & Zeller, H. (2001). West Nile in the Mediterranean 
Basin: 1950‐2000. Annals of the New York Academy of Sciences, 951(1), 117-126.  
 
Musso, D., Nilles, E., & Cao-Lormeau, V.-M. (2014). Rapid spread of emerging Zika virus in 
the Pacific area. Clinical Microbiology and Infection, 20(10), O595-O596.  
 
Muylaert, I. R., Chambers, T. J., Galler, R., & Rice, C. M. (1996). Mutagenesis of the N-linked 
glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and 
mouse neurovirulence. Virology, 222(1), 159-168.  
 
Nash, D., Mostashari, F., Fine, A., Miller, J., O'Leary, D., Murray, K., . . . Sherman, M. (2001). 
The outbreak of West Nile virus infection in the New York City area in 1999. New 
England Journal of Medicine, 344(24), 1807-1814.  
 
Nomaguchi, M., Teramoto, T., Yu, L., Markoff, L., & Padmanabhan, R. (2004). Requirements 
for West Nile virus (–)-and (+)-strand subgenomic RNA synthesis in vitro by the viral 
RNA-dependent RNA polymerase expressed in Escherichia coli. Journal of Biological 
Chemistry, 279(13), 12141-12151.  
Nowak, T., & Wengler, G. (1987). Analysis of disulfides present in the membrane proteins of the 
West Nile flavivirus. Virology, 156(1), 127-137.  
 
Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastere, S., Valour, F., . . . Ghawche, F. 
(2014). Zika virus infection complicated by Guillain-Barre syndrome--case report, 
French Polynesia, December 2013. Euro Surveill, 19(9), 20720.  
 
Olson, J., & Ksiazek, T. (1981). Zika virus, a cause of fever in Central Java, Indonesia. Trans R 
Soc Trop Med Hyg, 75(3), 389-393.  
 
Paupy, C., Delatte, H., Bagny, L., Corbel, V., & Fontenille, D. (2009). Aedes albopictus, an 
arbovirus vector: from the darkness to the light. Microbes and Infection, 11(14), 1177-
1185.  
 
Perrone, J. B., & Spielman, A. (1988). Time and site of assembly of the peritrophic membrane of 
the mosquito Aedes aegypti. Cell and tissue research, 252(2), 473-478.  
 
79 
 
Philip, C., & Smadel, J. (1943). Transmission of West Nile virus by infected Aedes albopictus. 
Proceedings of the Society for Experimental Biology and Medicine, 53(1), 49-50.  
 
Pijlman, G.P., Funk, A., Kondratieva, N., Leung, J., Torres, S., Van der Aa, L., Liu, W.J., 
Palmenberg, A.C., Shi, P.-Y., and Hall, R.A. (2008). A highly structured, nuclease-
resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell 
host & microbe 4, 579-591. 
 
Ponlawat, A., & Harrington, L. C. (2005). Blood feeding patterns of Aedes aegypti and Aedes 
albopictus in Thailand. Journal of Medical Entomology, 42(5), 844-849.  
 
Post, P. R., Carvalho, R., & Galler, R. (1991). Glycosylation and secretion of yellow fever virus 
nonstmctural protein NS1. Virus Research, 18(2), 291-302.  
 
Powell, J. R., & Tabachnick, W. J. (2013). History of domestication and spread of Aedes 
aegypti-A Review. Mem Inst Oswaldo Cruz, 108, 11-17.  
 
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995). The envelope 
glycoprotein from tick-borne encephalitis virus at 2 Å resolution.  
 
Reisen, W.K., Chiles, R.E., Kramer, L.D., Martinez, V.M., and Eldridge, B.F. (2000). Method of 
 infection does not alter response of chicks and house finches to western equine  
 encephalomyelitis and St. Louis encephalitis viruses. Journal of medical entomology 37, 
 250-258. 
 
Ribeiro, J., Rossignol, P., & Spielman, A. (1984). Role of mosquito saliva in blood vessel 
 location. Journal of Experimental Biology, 108(1), 1-7.  
 
Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L., & Strauss, J. H. (1985). 
Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression 
and evolution. Science, 229(4715), 726-733.  
 
Robin, Y., & Mouchet, J. (1974). [Serological and entomological study on yellow fever in Sierra 
Leone]. Bulletin de la Societe de Pathologie Exotique et de ses Filiales, 68(3), 249-258.  
Romoser, W., Turell, M., Lerdthusnee, K., Neira, M., Dohm, D., Ludwig, G., & Wasieloski, L. 
(2005). Pathogenesis of Rift Valley fever virus in mosquitoes—tracheal conduits & the 
basal lamina as an extra-cellular barrier Infectious Diseases from Nature: Mechanisms of 
Viral Emergence and Persistence (pp. 89-100): Springer. 
 
Rossi, S.L., Fayzulin, R., Dewsbury, N., Bourne, N., and Mason, P.W. (2007). Mutations in 
West Nile virus nonstructural proteins that facilitate replicon persistence in vitro 
attenuate virus replication in vitro and in vivo. Virology 364, 184-195. 
Roubaud, E. (1929). Autogenous Cycle of Winter Generations of Culex pipiens L. Compte 
Rendu de l'Academie des Sciences, 188(10), 735-738.  
 
80 
 
Salazar, M. I., Richardson, J. H., Sánchez-Vargas, I., Olson, K. E., & Beaty, B. J. (2007). 
Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti 
mosquitoes. BMC microbiology, 7(1), 1.  
 
Samuel, G. H., Wiley, M. R., Badawi, A., Adelman, Z. N., & Myles, K. M. (2016). Yellow fever 
virus capsid protein is a potent suppressor of RNA silencing that binds double-stranded 
RNA. Proceedings of the National Academy of Sciences, 113(48), 13863-13868.  
 
Schmid, M.A., Glasner, D.R., Shah, S., Michlmayr, D., Kramer, L.D., and Harris, E. (2016). 
Mosquito saliva increases endothelial permeability in the skin, immune cell migration, 
and dengue pathogenesis during antibody-dependent enhancement. PLoS Pathog 12, 
e1005676. 
 
Schneider, B.S., and Higgs, S. (2008). The enhancement of arbovirus transmission and disease 
by mosquito saliva is associated with modulation of the host immune response. 
Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 400-408. 
 
Schneider, B. S., McGee, C. E., Jordan, J. M., Stevenson, H. L., Soong, L., & Higgs, S. (2007). 
Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West 
Nile virus infection. Plos One, 2(11), e1171.  
 
Schneider, B. S., Soong, L., Coffey, L. L., Stevenson, H. L., McGee, C. E., & Higgs, S. (2010). 
Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-
presenting cells during West Nile virus infection. Plos One, 5(7), e11704.  
 
Schneider, B. S., Soong, L., Girard, Y. A., Campbell, G., Mason, P., & Higgs, S. (2006). 
Potentiation of West Nile encephalitis by mosquito feeding. Viral Immunology, 19(1), 74-
82.  
 
Schnettler, E., Sterken, M.G., Leung, J.Y., Metz, S.W., Geertsema, C., Goldbach, R.W., Vlak, 
J.M., Kohl, A., Khromykh, A.A., and Pijlman, G.P. (2012). Noncoding flavivirus RNA 
displays RNA interference suppressor activity in insect and Mammalian cells. J. Virol. 
86, 13486-13500. 
 
Schuessler, A., Funk, A., Lazear, H.M., Cooper, D.A., Torres, S., Daffis, S., Jha, B.K., Kumagai, 
Y., Takeuchi, O., and Hertzog, P. (2012). West Nile virus noncoding subgenomic RNA 
contributes to viral evasion of the type I interferon-mediated antiviral response. J. Virol. 
86, 5708-5718. 
 
Shi, P.-Y., Li, W., & Brinton, M. A. (1996). Cell proteins bind specifically to West Nile virus 
minus-strand 3'stem-loop RNA. Journal of Virology, 70(9), 6278-6287.  
 
Silva, R.L., de Silva, A.M., Harris, E., and MacDonald, G.H. (2008). Genetic analysis of Dengue 
3 virus subtype III 5′ and 3′ non-coding regions. Virus research 135, 320-325. 
 
81 
 
Simonin, Y., Loustalot, F., Desmetz, C., Foulongne, V., Constant, O., Fournier-Wirth, C., . . . 
Lemaitre, J.-M. (2016). Zika virus strains potentially display different infectious profiles 
in human neural cells. EBioMedicine, 12, 161-169.  
 
Smith, T. J., Brandt, W. E., Swanson, J. L., McCown, J. M., & Buescher, E. L. (1970). Physical 
and biological properties of dengue-2 virus and associated antigens. Journal of Virology, 
5(4), 524-532.  
 
Smithburn, K. (1952). Neutralizing antibodies against certain recently isolated viruses in the sera 
of human beings residing in East Africa. The Journal of Immunology, 69(2), 223-234.  
 
Smithburn, K., Hughes, T., Burke, A., & Paul, J. (1940). A neurotropic virus isolated from the 
blood of a native of Uganda. American Journal of Tropical Medicine, 20, 471-472.  
 
Smithburn, K. C. (1942). Differentiation of the West Nile Virus from the Viruses of St. Louis 
and Japanese B Encephalitis. Journal of Immunology, 43(5), 25-31.  
 
Spielman, A. (2001). Structure and seasonality of nearctic Culex pipiens populations. Annals of 
the New York Academy of Sciences, 951(1), 220-234.  
Stadler, K., Allison, S. L., Schalich, J., & Heinz, F. X. (1997). Proteolytic activation of tick-
borne encephalitis virus by furin. Journal of Virology, 71(11), 8475-8481.  
 
Stauft, C. B., Gorbatsevych, O., Cello, J., Wimmer, E., & Futcher, B. (2016). Comparison of 
African, Asian, and American Zika Viruses in Swiss Webster mice: Virulence, 
neutralizing antibodies, and serotypes. bioRxiv, 075747.  
 
Styer, L. M., Bernard, K. A., & Kramer, L. D. (2006). Enhanced early West Nile virus infection 
in young chickens infected by mosquito bite: effect of viral dose. The American journal 
of tropical medicine and hygiene, 75(2), 337-345.  
 
Styer, L. M., Lim, P.-Y., Louie, K. L., Albright, R. G., Kramer, L. D., & Bernard, K. A. (2011). 
Mosquito saliva causes enhancement of West Nile virus infection in mice. Journal of 
Virology, 85(4), 1517-1527.  
 
Sztuba-Solinska, J., Teramoto, T., Rausch, J.W., Shapiro, B.A., Padmanabhan, R., and Le Grice, 
S.F. (2013). Structural complexity of Dengue virus untranslated regions: cis-acting RNA 
motifs and pseudoknot interactions modulating functionality of the viral genome. Nucleic 
acids research, gkt203. 
 
Tabachnick, W. J. (1991). Evolutionary genetics and arthropod-borne disease: the yellow fever 
mosquito. American Entomologist, 37(1), 14-26.  
 
Takahashi, M. (1976). The effects of environmental and physiological conditions of Culex 
tritaeniorhynchus on the pattern of transmission of Japanese encephalitis virus. Journal 
of Medical Entomology, 13(3), 275-284.  
 
82 
 
Takamatsu, Y., Okamoto, K., Dinh, D.T., Yu, F., Hayasaka, D., Uchida, L., Nabeshima, T., 
Buerano, C.C., and Morita, K. (2014). NS1′ protein expression facilitates production of 
Japanese encephalitis virus in avian cells and embryonated chicken eggs. Journal of 
General Virology 95, 373-383. 
 
Thielman, A. C., & Hunter, F. F. (2007). A photographic key to adult female mosquito species of 
Canada (Diptera: Culicidae): Biological Survey of Canada. 
 
Titus, R., Bishop, J., & Mejia, J. (2006). The immunomodulatory factors of arthropod saliva and 
the potential for these factors to serve as vaccine targets to prevent pathogen 
transmission. Parasite Immunology, 28(4), 131-141.  
 
Trent, D. W. (1977). Antigenic characterization of flavivirus structural proteins separated by 
isoelectric focusing. Journal of Virology, 22(3), 608-618.  
 
Turell, M., Sardelis, M., O’guinn, M., & Dohm, D. (2002). Potential vectors of West Nile virus 
in North America Japanese encephalitis and West Nile viruses (pp. 241-252): Springer. 
 
Valenzuela, J., Pham, V., Garfield, M., Francischetti, I., & Ribeiro, J. (2002). Toward a 
description of the sialome of the adult female mosquito Aedes aegypti. Insect 
biochemistry and molecular biology, 32(9), 1101-1122.  
 
Valenzuela, J. G., Francischetti, I. M., Pham, V. M., Garfield, M. K., & Ribeiro, J. M. (2003). 
Exploring the salivary gland transcriptome and proteome of the Anopheles stephensi 
mosquito. Insect biochemistry and molecular biology, 33(7), 717-732.  
 
Vinogradova, E. B. (2000). Culex pipiens pipiens mosquitoes: taxonomy, distribution, ecology, 
physiology, genetics, applied importance and control: Pensoft Publishers. 
 
Wang, E., Weaver, S.C., Shope, R.E., Tesh, R.B., Watts, D.M., and Barrett, A.D. (1996). 
Genetic variation in yellow fever virus: duplication in the 3′ noncoding region of strains 
from Africa. Virology 225, 274-281. 
Weaver, S., Scott, T., Lorenz, L., Lerdthusnee, K., & Romoser, W. (1988). Togavirus-associated 
pathologic changes in the midgut of a natural mosquito vector. Journal of Virology, 
62(6), 2083-2090.  
 
Weaver, S. C., Costa, F., Garcia-Blanco, M. A., Ko, A. I., Ribeiro, G. S., Saade, G., . . . 
Vasilakis, N. (2016). Zika virus: history, emergence, biology, and prospects for control. 
Antiviral Res, 130, 69-80.  
 
Weger-Lucarelli, J., Rückert, C., Chotiwan, N., Nguyen, C., Luna, S. M. G., Fauver, J. R., . . . 
Kading, R. C. (2016). Vector Competence of American Mosquitoes for Three Strains of 
Zika Virus. PLoS Negl Trop Dis, 10(10), e0005101.  
 
83 
 
Weingartl, H., Neufeld, J., Copps, J., & Arszal, P. (2004). Experimental West Nile virus 
infection in blue jays (Cyanocitta cristata) and crows (Corvus brachyrhynchos). 
Veterinary Pathology Online, 41(4), 362-370.  
 
Wengler, G., Wengler, G., & Gross, H. J. (1978). Studies on virus-specific nucleic acids 
synthesized in vertebrate and mosquito cells infected with flaviviruses. Virology, 89(2), 
423-437.  
 
Westaway, E. G., Khromykh, A. A., Kenney, M. T., Mackenzie, J. M., & Jones, M. K. (1997). 
Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus. 
Virology, 234(1), 31-41.  
 
Westaway, E. G., Mackenzie, J. M., Kenney, M. T., Jones, M. K., & Khromykh, A. A. (1997). 
Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-
stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. Journal of 
Virology, 71(9), 6650-6661.  
 
Whitfield, S. G., Murphy, F. A., & Sudia, W. D. (1973). St. Louis encephalitis virus: an 
ultrastructural study of infection in a mosquito vector. Virology, 56(1), 70-87.  
 
Winkler, G., Randolph, V. B., Cleaves, G. R., Ryan, T. E., & Stollar, V. (1988). Evidence that 
the mature form of the flavivirus nonstructural protein NS1 is a dimer. Virology, 162(1), 
187-196.  
 
Work, T. H., HURLBÜT, H., & Taylor, R. (1955). Indigenous wild birds of the Nile Delta as 
potential West Nile virus circulating reservoirs. American Journal of Tropical Medicine 
and Hygiene, 4(5), 872-888.  
 
Xi, Z., Ramirez, J.L., and Dimopoulos, G. (2008). The Aedes aegypti toll pathway controls 
dengue virus infection. PLoS Pathog 4, e1000098. 
 
Xiao, S.-Y., Guzman, H., Zhang, H., Da Rosa, A. T., & Tesh, R. B. (2001). West Nile virus 
infection in the golden hamster (Mesocricetus auratus): a model for West Nile 
encephalitis. Emerging Infectious Diseases, 7(4), 714.  
 
Young, L.B., Melian, E.B., and Khromykh, A.A. (2013). NS1′ colocalizes with NS1 and can 
substitute for NS1 in West Nile virus replication. J. Virol. 87, 9384-9390. 
 
Yu, C.-Y., Chang, T.-H., Liang, J.-J., Chiang, R.-L., Lee, Y.-L., Liao, C.-L., and Lin, Y.-L. 
(2012). Dengue virus targets the adaptor protein MITA to subvert host innate immunity. 
PLoS Pathog 8, e1002780. 
Yu, I.-M., Holdaway, H. A., Chipman, P. R., Kuhn, R. J., Rossmann, M. G., & Chen, J. (2009). 
Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. 
Journal of Virology, 83(23), 12101-12107.  
 
84 
 
Zanluca, C., Melo, V. C. A. d., Mosimann, A. L. P., Santos, G. I. V. d., Santos, C. N. D. d., & 
Luz, K. (2015). First report of autochthonous transmission of Zika virus in Brazil. Mem 
Inst Oswaldo Cruz, 110(4), 569-572.  
 
Zhang, X., Ge, P., Yu, X., Brannan, J. M., Bi, G., Zhang, Q., . . . Zhou, Z. H. (2013). Cryo-EM 
structure of the mature dengue virus at 3.5-Å resolution. Nature structural & molecular 
biology, 20(1), 105-110.  
 
Zhang, Y., Corver, J., Chipman, P. R., Zhang, W., Pletnev, S. V., Sedlak, D., . . . Rossmann, M. 
G. (2003). Structures of immature flavivirus particles. The EMBO Journal, 22(11), 2604-
2613.  
 
Zheng, A., Yuan, F., Kleinfelter, L.M., and Kielian, M. (2014). A toggle switch controls the low 
pH-triggered rearrangement and maturation of the dengue virus envelope proteins. 
Nature communications 5. 
 
Appendix 
 
Recipes 
Larval Feed 
Mix 1:1 Brewer’s yeast and crushed Tetramin™ fish food with pestle and mortar and 
store in sealed container in cooled, dry place. 
10% Sucrose Solution 
For 100 mL, weigh 10 grams of sucrose and pour into 70 mL of tap water. Mix and then 
fill to 100 mL. Autoclave and store in refrigerator. 
SDS PAGE Sample Buffer 
Mix 1.0 mL of 0.5mM Tris-HCl with pH 6.8, 2.0 ml of 25% glycerol, 0.08 mL of 1.0% 
bromophenol blue, 1.6 mL of 10% SDS, and 2.92 mL of deionized water, Add 0.4 mL of 
β-mercaptoethanol immediately before use. 
Viral Sugar Solution 
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Mix 4.65ml of Dulbecco's Modified Eagle Medium High Glucose (DMEM), 0.75ml of 
40% sucrose solution, and 0.6ml of 10^6 PFU ZIKV. Final concentration of virus is 10^5 
PFU. Solution is warmed to 37°C before use. 
Mosquito Diluent Solution 
To make 100 mL, add 2 mL of FBS to 98 mL of DMEM. Keep refrigerated. 
 
Mosquito Saliva Collection Solution  
 For 100 mL, mix 50 mL of 10% sucrose solution with 50 mL stock FBS solution. 
 
Chapter 4 Data 
                                                                                           
PCR Quantification Report 
PCR Base Line Subtracted Curve Fit Data 
 
Current Date:  19-Sep-16 10:47 AM 
Data generated on: 16-Sep-16 at 12:38 AM. 
 
Optical data file name: zika 10dpi culex sept 16.odm 
Plate Setup file used: sept15zika.psm 
Protocol file used: ZIKA.tmo 
 
Sample volume: 25.00 ul 
Hot Start? No  
Well factor collection: Experimental Plate 
 
Comments 
 
 
 
Protocol 
 
 
Cycle  1: (  1X)  
 Step  1:   50.0ºC for 30:00 
Cycle  2: (  1X)  
 Step  1:   95.0ºC for 15:00 
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Cycle  3: ( 40X)  
 Step  1:   94.0ºC for 00:15 
 Step  2:   60.0ºC for 01:00 
 Data collection and real-time analysis enabled. 
Cycle  4: (  1X)  
 Step  1:    4.0ºC HOLD 
  
PCR Amp/Cycle Graph for FAM-490  
 
Data Analysis Parameters 
 
Calculated threshold has been replaced by the user selected threshold 63.9. 
Per-well baseline cycles have been determined automatically.   
Data analysis window is set at 95.00% of a cycle, centered at end of the cycle. 
Weighted Mean digital filtering has been applied. Global filtering is off. 
 
PCR Quantification Spreadsheet Data for FAM-490  
 
Well Identifier Ct Setpoint 
  
A01  N/A  
A02  N/A  
A03  N/A  
A04  N/A  
A05  N/A  
A06  N/A  
A07  N/A  
A08  N/A  
A09  N/A  
A10  N/A  
A11  N/A  
A12  N/A  
B01  N/A  
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B02  N/A  
B03  N/A  
B04  N/A  
B05  N/A  
B06  N/A  
B07  N/A  
B08  N/A  
B09  N/A  
B10  N/A  
B11  N/A  
B12  N/A  
C01  N/A  
C02  N/A  
C03  N/A  
C04  N/A  
C05  N/A  
C06  N/A  
C07  N/A  
C08  N/A  
C09  N/A  
C10  N/A  
C11  N/A  
C12  N/A  
D01  N/A  
D02  N/A  
D03  N/A  
D04  N/A  
D05  N/A  
D06  N/A  
D07  N/A  
D08  N/A  
D09  N/A  
D10  N/A  
D11  N/A  
D12  N/A  
E01  N/A  
E02  N/A  
E03  N/A  
E04  N/A  
E05  N/A  
E06  N/A  
E07  N/A  
E08  N/A  
E09  N/A  
E10  N/A  
E11  N/A  
E12  N/A  
F01  N/A  
F02  N/A  
F03  N/A  
F04  N/A  
F05  N/A  
F06  N/A  
F07  N/A  
F08  N/A  
F09  N/A  
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F10  N/A  
F11  N/A  
F12  N/A  
G01  N/A  
G02  N/A  
G03  N/A  
G04  N/A  
G05  N/A  
G06  N/A  
G07  N/A  
G08  N/A  
G09  38.01  
G10  N/A  
G11  N/A  
G12  N/A  
H07  N/A  
H08  N/A  
H10  18.59  
H11  22.21  
  
Wells Excluded from Analysis 
 
A total of 8 well(s) have been excluded from analysis. 
 
H01: <no identifier>           H02: <no identifier>           H03: <no identifier>           
H04: <no identifier>           H05: <no identifier>           H06: <no identifier>           
H09: <no identifier>           H12: <no identifier>            
  
Modified Well Contents 
 
No wells have been modified. 
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PCR Quantification Report 
PCR Base Line Subtracted Curve Fit Data 
 
Current Date:  19-Sep-16 10:51 AM 
Data generated on: 16-Sep-16 at 03:40 AM. 
 
Optical data file name: zika 10dpi culex 2 sept 16.odm 
Plate Setup file used: sept16.psm 
Protocol file used: ZIKA.tmo 
 
Sample volume: 25.00 ul 
Hot Start? No  
Well factor collection: Experimental Plate 
 
Comments 
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Protocol 
 
 
Cycle  1: (  1X)  
 Step  1:   50.0ºC for 30:00 
Cycle  2: (  1X)  
 Step  1:   95.0ºC for 15:00 
Cycle  3: ( 40X)  
 Step  1:   94.0ºC for 00:15 
 Step  2:   60.0ºC for 01:00 
 Data collection and real-time analysis enabled. 
Cycle  4: (  1X)  
 Step  1:    4.0ºC HOLD 
  
PCR Amp/Cycle Graph for FAM-490  
 
Data Analysis Parameters 
 
Calculated threshold using the maximum curvature approach is 9.2. 
Per-well baseline cycles have been determined automatically.   
Data analysis window is set at 95.00% of a cycle, centered at end of the cycle. 
Weighted Mean digital filtering has been applied. Global filtering is off. 
 
PCR Quantification Spreadsheet Data for FAM-490  
 
Well Identifier Ct Setpoint 
  
A02  N/A  
A03  N/A  
A04  N/A  
A05  N/A  
A06  N/A  
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A07  N/A  
A08  36.01  
A09  35.13  
A10  27.37  
A11  N/A  
B01  N/A  
B02  N/A  
B03  35.54  
B04  N/A  
B05  N/A  
B06  N/A  
B07  N/A  
B08  N/A  
B09  N/A  
B10  N/A  
B11  35.22  
B12  36.19  
C01  35.07  
C02  N/A  
C03  37.24  
C04  N/A  
C05  N/A  
C06  N/A  
C07  N/A  
C08  37.42  
C09  N/A  
C10  N/A  
C11  N/A  
C12  37.51  
D01  N/A  
D02  N/A  
D03  N/A  
D04  36.70  
D05  N/A  
D06  37.08  
D07  N/A  
D08  36.99  
D09  N/A  
D10  34.99  
D11  N/A  
D12  35.86  
E01  N/A  
E02  36.28  
E03  N/A  
E04  N/A  
E05  N/A  
E06  N/A  
E07  N/A  
E08  N/A  
E09  N/A  
E10  34.56  
E11  37.71  
E12  34.49  
F01  N/A  
F02  35.67  
F03  N/A  
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F04  N/A  
F05  N/A  
F06  N/A  
H07  N/A  
H08  N/A  
H10  18.08  
H11  22.05  
  
Wells Excluded from Analysis 
 
A total of 28 well(s) have been excluded from analysis. 
 
A01: <no identifier>           A12: <no identifier>           F07: <no identifier>           
F08: <no identifier>           F09: <no identifier>           F10: <no identifier>           
F11: <no identifier>           F12: <no identifier>           G01: <no identifier>           
G02: <no identifier>           G03: <no identifier>           G04: <no identifier>           
G05: <no identifier>           G06: <no identifier>           G07: <no identifier>           
G08: <no identifier>           G09: <no identifier>           G10: <no identifier>           
G11: <no identifier>           G12: <no identifier>           H01: <no identifier>           
H02: <no identifier>           H03: <no identifier>           H04: <no identifier>           
H05: <no identifier>           H06: <no identifier>           H09: <no identifier>           
H12: <no identifier>             
  
Modified Well Contents 
 
No wells have been modified. 
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PCR Quantification Report 
PCR Base Line Subtracted Curve Fit Data 
 
Current Date:  19-Sep-16 10:53 AM 
Data generated on: 16-Sep-16 at 06:18 PM. 
 
Optical data file name: zika 14dpi culex sept 16.odm 
Plate Setup file used: sept16-14dpi.psm 
Protocol file used: ZIKA.tmo 
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Sample volume: 25.00 ul 
Hot Start? No  
Well factor collection: Experimental Plate 
 
Comments 
 
 
 
Protocol 
 
 
Cycle  1: (  1X)  
 Step  1:   50.0ºC for 30:00 
Cycle  2: (  1X)  
 Step  1:   95.0ºC for 15:00 
Cycle  3: ( 40X)  
 Step  1:   94.0ºC for 00:15 
 Step  2:   60.0ºC for 01:00 
 Data collection and real-time analysis enabled. 
Cycle  4: (  1X)  
 Step  1:    4.0ºC HOLD 
  
PCR Amp/Cycle Graph for FAM-490  
 
Data Analysis Parameters 
 
Calculated threshold has been replaced by the user selected threshold 43.9. 
Per-well baseline cycles have been determined automatically.   
Data analysis window is set at 95.00% of a cycle, centered at end of the cycle. 
Weighted Mean digital filtering has been applied. Global filtering is off. 
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PCR Quantification Spreadsheet Data for FAM-490  
 
Well Identifier Ct Setpoint 
  
A02  N/A  
A03  N/A  
A04  N/A  
A05  N/A  
A06  N/A  
A07  N/A  
A08  N/A  
A09  N/A  
A10  N/A  
A11  N/A  
B01  N/A  
B02  N/A  
B03  N/A  
B04  37.80  
B05  N/A  
B06  N/A  
B07  N/A  
B08  N/A  
B09  N/A  
B10  37.38  
B11  38.25  
B12  N/A  
C01  N/A  
C02  N/A  
C03  N/A  
C04  N/A  
C05  N/A  
C06  N/A  
C07  N/A  
C08  N/A  
C09  N/A  
C10  N/A  
C11  N/A  
C12  N/A  
D01  N/A  
D02  N/A  
D03  N/A  
D04  N/A  
D05  N/A  
D06  N/A  
D07  N/A  
D08  N/A  
D09  N/A  
D10  N/A  
D11  N/A  
D12  N/A  
E01  N/A  
E02  N/A  
E03  N/A  
E04  N/A  
E05  N/A  
E06  N/A  
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E07  N/A  
E08  N/A  
E09  N/A  
E10  37.39  
E11  N/A  
E12  N/A  
F01  N/A  
F02  N/A  
F03  N/A  
F04  N/A  
F05  N/A  
F06  N/A  
F07  N/A  
F08  N/A  
F09  N/A  
F10  N/A  
F11  N/A  
F12  N/A  
G01  N/A  
G02  N/A  
G03  N/A  
G04  N/A  
G05  N/A  
G06  37.69  
G07  N/A  
G08  N/A  
G09  N/A  
G10  N/A  
G11  N/A  
G12  N/A  
H07  N/A  
H08  N/A  
H10  18.14  
H11  22.68  
  
Wells Excluded from Analysis 
 
A total of 10 well(s) have been excluded from analysis. 
 
A01: <no identifier>           A12: <no identifier>           H01: <no identifier>           
H02: <no identifier>           H03: <no identifier>           H04: <no identifier>           
H05: <no identifier>           H06: <no identifier>           H09: <no identifier>           
H12: <no identifier>             
  
Modified Well Contents 
 
No wells have been modified. 
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PCR Quantification Report 
PCR Base Line Subtracted Curve Fit Data 
 
Current Date:  19-Sep-16 10:56 AM 
Data generated on: 16-Sep-16 at 10:12 PM. 
 
Optical data file name: zika 14dpi culex 2 sept 16.odm 
Plate Setup file used: sept15-14dpi 2.psm 
Protocol file used: ZIKA.tmo 
 
Sample volume: 25.00 ul 
Hot Start? No  
Well factor collection: Experimental Plate 
 
Comments 
 
 
 
Protocol 
 
98 
 
 
Cycle  1: (  1X)  
 Step  1:   50.0ºC for 30:00 
Cycle  2: (  1X)  
 Step  1:   95.0ºC for 15:00 
Cycle  3: ( 40X)  
 Step  1:   94.0ºC for 00:15 
 Step  2:   60.0ºC for 01:00 
 Data collection and real-time analysis enabled. 
Cycle  4: (  1X)  
 Step  1:    4.0ºC HOLD 
  
PCR Amp/Cycle Graph for FAM-490  
 
Data Analysis Parameters 
 
Calculated threshold using the maximum curvature approach is 15.3. 
Per-well baseline cycles have been determined automatically.   
Data analysis window is set at 95.00% of a cycle, centered at end of the cycle. 
Weighted Mean digital filtering has been applied. Global filtering is off. 
 
PCR Quantification Spreadsheet Data for FAM-490  
 
Well Identifier Ct Setpoint 
  
A02  N/A  
A03  N/A  
A04  N/A  
A05  N/A  
A06  N/A  
A07  N/A  
A08  N/A  
A09  N/A  
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H08  19.03  
H09  23.54  
  
Wells Excluded from Analysis 
 
A total of 86 well(s) have been excluded from analysis. 
 
A01: <no identifier>           A10: <no identifier>           A11: <no identifier>           
A12: <no identifier>           B01: <no identifier>           B02: <no identifier>           
B03: <no identifier>           B04: <no identifier>           B05: <no identifier>           
B06: <no identifier>           B07: <no identifier>           B08: <no identifier>           
B09: <no identifier>           B10: <no identifier>           B11: <no identifier>           
B12: <no identifier>           C01: <no identifier>           C02: <no identifier>           
C03: <no identifier>           C04: <no identifier>           C05: <no identifier>           
C06: <no identifier>           C07: <no identifier>           C08: <no identifier>           
C09: <no identifier>           C10: <no identifier>           C11: <no identifier>           
C12: <no identifier>           D01: <no identifier>           D02: <no identifier>           
D03: <no identifier>           D04: <no identifier>           D05: <no identifier>           
D06: <no identifier>           D07: <no identifier>           D08: <no identifier>           
D09: <no identifier>           D10: <no identifier>           D11: <no identifier>           
D12: <no identifier>           E01: <no identifier>           E02: <no identifier>           
E03: <no identifier>           E04: <no identifier>           E05: <no identifier>           
E06: <no identifier>           E07: <no identifier>           E08: <no identifier>           
E09: <no identifier>           E10: <no identifier>           E11: <no identifier>           
E12: <no identifier>           F01: <no identifier>           F02: <no identifier>           
F03: <no identifier>           F04: <no identifier>           F05: <no identifier>           
F06: <no identifier>           F07: <no identifier>           F08: <no identifier>           
F09: <no identifier>           F10: <no identifier>           F11: <no identifier>           
F12: <no identifier>           G01: <no identifier>           G02: <no identifier>           
G03: <no identifier>           G04: <no identifier>           G05: <no identifier>           
G06: <no identifier>           G07: <no identifier>           G08: <no identifier>           
G09: <no identifier>           G10: <no identifier>           G11: <no identifier>           
G12: <no identifier>           H01: <no identifier>           H02: <no identifier>           
H03: <no identifier>           H04: <no identifier>           H05: <no identifier>           
H06: <no identifier>           H07: <no identifier>           H10: <no identifier>           
H11: <no identifier>           H12: <no identifier>            
  
Modified Well Contents 
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No wells have been modified.      
Table 2: Cx. pipiens qRT-PCR Ct- values for positive ZIKV samples after 10  
d.p.i. Samples highlighted in red indicate potential positive.  
 
 
 
Cx. pipiens (10 d.p.i.)     
 Sample  Ct Value  
  Body  Leg/ Wings Saliva 
 1 N/A N/A N/A 
 2 N/A N/A N/A 
 3 N/A N/A N/A 
 4 N/A N/A N/A 
 5 N/A N/A N/A 
 6 N/A N/A N/A 
 7 N/A N/A N/A 
 8 N/A N/A N/A 
 9 N/A N/A N/A 
 10 N/A N/A N/A 
 11 N/A N/A N/A 
 12 N/A N/A N/A 
 13 N/A N/A N/A 
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 14 N/A N/A N/A 
 15 N/A N/A N/A 
 16 N/A N/A N/A 
 17 N/A N/A N/A 
 18 N/A N/A N/A 
 19 N/A N/A N/A 
 20 N/A N/A N/A 
 21 N/A N/A N/A 
 22 N/A N/A N/A 
 23 N/A N/A N/A 
 24 N/A N/A N/A 
 25 N/A N/A N/A 
 26 N/A N/A N/A 
 27 N/A N/A 38.01 
 28 N/A N/A N/A 
 29 N/A N/A N/A 
 30 N/A N/A N/A 
 31 N/A 36.01 35.13 
 32 27.37 N/A N/A 
 33 N/A N/A 35.54 
 34 N/A N/A N/A 
 35 N/A N/A N/A 
 36 N/A 35.22 36.19 
 37 35.07 N/A 37.24 
 38 N/A N/A N/A 
 39 N/A 37.42 N/A 
 40 N/A N/A 37.51 
 41 N/A N/A N/A 
 42 36.7 N/A 37.08 
 43 N/A 36.99 N/A 
 44 34.99 N/A 35.86 
 45 N/A 36.28 N/A 
 46 N/A N/A N/A 
 47 N/A N/A N/A 
 48 34.56 37.71 34.49 
 49 N/A 35.67 N/A 
 50 N/A N/A N/A 
      
  
Table 3: Cx. pipiens qRT-PCR Ct- values for positive ZIKV samples after 14  
d.p.i. Sample highlighted in red indicate potential positive.  
 
102 
 
Culex pipiens (14 d.p.i.) 1 N/A N/A N/A 
 2 N/A N/A N/A 
 3 N/A N/A N/A 
 4 N/A N/A N/A 
 5 N/A N/A N/A 
 6 37.08 N/A N/A 
 7 N/A N/A N/A 
 8 N/A 38.25 37.38 
 9 N/A N/A N/A 
 10 N/A N/A N/A 
 11 N/A N/A N/A 
 12 N/A N/A N/A 
 13 N/A N/A N/A 
 14 N/A N/A N/A 
 15 N/A N/A N/A 
 16 N/A N/A N/A 
 17 N/A N/A N/A 
 18 N/A N/A N/A 
 19 N/A N/A N/A 
 20 37.39 N/A N/A 
 21 N/A N/A N/A 
 22 N/A N/A N/A 
 23 N/A N/A N/A 
 24 N/A N/A N/A 
 25 N/A N/A N/A 
 26 N/A N/A 37.69 
 27 N/A N/A N/A 
 28 N/A N/A N/A 
 29 N/A N/A N/A 
 30 N/A N/A N/A 
 31 N/A N/A N/A 
 32 N/A N/A N/A 
 
